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ABSTRACT 
Infectious disease can play a vital role in species conservation, as some diseases 
can cause massive population die-offs. In North American tortoises, population declines 
have been attributed to an upper respiratory tract disease, but the importance of this 
disease within and among tortoise hosts is controversial. In this dissertation, I use 
samples from the upper respiratory tract of wild tortoises representing multiple species in 
the genus Gopherus to answer questions regarding pathogen prevalence and co-infection, 
pathogen genetic diversity, and the ecology of pathogens within the upper respiratory 
tracts of tortoises. Using genetic methods including polymerase chain reaction (PCR), 
quantitative PCR, Sanger sequencing, and 454-pyrosequencing, the data presented herein 
supports hypotheses that pathogens in this disease system interact with each other and 
with other microbes in the respiratory tract differently in different tortoise host species. 
In this system, both transmission and disease progression are found to be 
extremely slow in these long-lived hosts. Though pathogens were widespread among the 
sampled tortoises, few individuals were found with clinical signs of disease. Few 
individuals capable of transmitting disease (requiring nasal mucus and pathogen), along 
with few opportunities for pathogen transmission (requiring long periods of direct 
contact), indicate that it is unlikely for tortoises to fully clear themselves of these 
microbes without risk of the pathogen’s extinction. If this is the case, then it is likely that 
more tortoises than we can detect have these microbes in their upper respiratory tracts. 
With this in mind, and considering the abundance of visibly healthy tortoises over ill 
tortoises, my collaborators and I suspect that pathogens in this system likely form 
	 ii	
commensal relationships with their hosts much of the time, until a stressor alters the 
system and leads to a parasitic interaction. 
The results of this dissertation indicate that this disease is context dependent, 
depending on the host and likely other microbes in the community. Our understanding of 
the ecology of this disease system would greatly benefit from experimental inoculation 
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The tortoise genus Gopherus, a group of land turtles most closely related to the 
Asian genus Manouria (Le et al. 2006), includes six species inhabiting North America. 
Of those species, four have partial or entire distributions in the U.S.: the gopher tortoise 
(G. polyphemus) lives in the southeastern U.S.; Texas tortoises (G. berlandieri) are found 
from southern Texas into Mexico; Mojave desert tortoises (G. agassizii) are found in the 
Mojave and Colorado Deserts of the U.S. southwest; and the recently described Sonoran 
desert (Morafka’s) tortoise (G. morafkai; Murphy et al. 2011) inhabits the Sonoran Desert 
of Arizona into Mexico. Previous research on the phylogeny of these species splits them 
into two groups, one including the desert tortoises and Texas tortoise, with the gopher 
and bolson (G. flavomarginatus) tortoises splitting off as sister taxa to each other (Berry 
et al. 2002, Reynoso and Montellano-Ballesteros 2004, Le et al. 2006).  
In 1990, the Mojave desert tortoise was listed as threatened under the Endangered 
Species Act of 1973 (U.S. Fish and Wildlife Service 1994), and an upper respiratory tract 
disease (URTD) has been implicated in population declines of the species (Jacobson et al. 
1991). Since the early 1990s, URTD has also been implicated as a cause of population 
declines in the gopher tortoise (Seigel et al. 2003, Enge et al. 2006), though further 
investigation indicates lower impacts of this disease on individual mortality and 
population declines than previously thought (Sandmeier et al. 2009, Florida Fish and 
Wildlife Conservation Commission 2012). This disease has also been detected in wild 
Sonoran desert tortoises (Dickinson et al. 2005), Texas tortoises (Judd and Rose 2000, 





Clinical signs of URTD include nasal exudate, palpebral edema, and wheezing, 
with severe cases resulting in lethargy and potentially mortality (Brown et al. 1994). 
Multiple pathogens are associated with URTD in North American tortoises, including 
Mycoplasma agassizii, M. testudineum, Pasteurella testudinis, testudinid herpesvirus 2, 
and an iridovirus (Snipes et al. 1980, Snipes and Biberstein 1982, Brown et al. 1994, 
1999b, 2004, Westhouse et al. 1996, Jacobson et al. 2012). Importantly, each pathogen 
does not necessarily cause all of the clinical signs associated with URTD. For example, 
M. agassizii has fulfilled Koch’s postulates, though palpebral edema was not a disease 
result from this pathogen (Brown et al. 1994).  
Mycoplasmal URTD was first detected in the western Mojave Desert in 
California after a population crash in the late 1980s (Berry 1990). This population crash, 
posited to be due to disease, spurred a flood of research regarding how URTD is spread, 
the extent to which the disease threatens tortoises, and detecting disease in tortoises via 
antibody responses (Jacobson et al. 1991, Schumacher et al. 1997, Brown et al. 1999a, 
Diemer Berish et al. 2000, Brown et al. 2002, Dickinson et al. 2005, Diemer Berish et al. 
2010, Sandmeier et al. 2013). However, until now, there has not been an organized study 
on pathogen presence and characteristics of mycoplasma populations across the Mojave 
Desert. 
Historically, the presence of URTD in tortoise populations has been deduced 
through several different assays that assessed for different aspects of disease: (a) presence 
of clinical signs (generally indicates disease, but without identifying the cause of the 
disease), (b) M. agassizii-specific antibody detection using both enzyme-linked 





response to a particular pathogen; e.g., Mycoplasma), and (c) mucus cultures, which 
directly assesses for the pathogen  (Schumacher et al. 1993, Brown et al. 2002, Hunter et 
al. 2008). More recently, a less-expensive assay using quantitative PCR assay was 
developed to detect pathogens directly rather than inferring pathogen presence from the 
presence of physiologically produced antibodies (Braun et al. 2014). There are still many 
gaps in our understanding of this disease, and not much is known about the bacterium, M. 
agassizii, itself – its virulence, its strain diversity, or its ecology. 
An important aspect of understanding a disease system is understanding pathogen 
transmission. In the case of M. agassizii, extended periods of direct contact between 
individuals is required for pathogen transmission (Aiello et al. 2016), followed by 
extremely slow disease progression (Maloney 2011). Among wild tortoises, this direct 
contact is likely associated with burrow sharing (Bulova 1994, Radzio et al. 2016), which 
could be defined by social interactions (Wendland et al. 2010). Importantly, there is no 
evidence for vertical transmission of M. agassizii (Schumacher et al. 1999), and the 
limited conditions in which this mycoplasma can grow means it is unlikely to survive 
outside of the host in the environment (Orlowski et al. 2015).  
Once a pathogen has colonized its host, its success is affected by interactions with 
co-infecting pathogens, the microbial community in the host, and the host’s immune 
system. Pathogens within a host can interact both directly and indirectly through the 
host’s immune response to result in positive, negative, and neutral interactions. 
Furthermore, these interactions are affected by the pathogens’ location within the host, 
recency of infection, and how chronic the infection is (Pedersen and Fenton 2007, Telfer 





The complexity of interactions within a host is compounded by the host’s immune 
strength, which can be shaped by host genotype and genotype-by-environment 
interactions. Immune genes determine the possible extent of an immune response, while 
environmental factors affect the performance of immune physiological traits. Food 
availability, affected by timing and amount of annual rainfall, along with harshness of 
winter, are environmental factors that could impact body condition and health. McCoy 
and colleagues (2011) found that amount of rainfall influenced body condition in Mojave 
desert tortoises, but not in gopher tortoises. In the Mojave Desert, local tortoise 
populations have been reported to have increased prevalence of antibodies to M. agassizii 
(indicating an assumed increase in disease) with an increase in number of days below 
freezing (Sandmeier et al. 2013), though this factor could be confounded by genotypic 
differences in tortoises inhabiting different environments across the desert southwest.  
URTD has been observed in populations across the Mojave Desert at varying 
frequencies through antibody detection (Sandmeier et al. 2013), and its importance at the 
population level continues to be controversial (Sandmeier et al. 2009). It is, thus, 
expected that pathogens are prevalent in tortoises across the Mojave Desert, but the 
presence within local populations may not necessarily coincide with prevalence of 
immune response. The likely range-wide prevalence of M. agassizii, and the varying 
prevalences of URTD in the gopher tortoise (McCoy et al. 2007) and Mojave desert 
tortoise (Sandmeier et al. 2009, 2013) populations indicate a broad range of disease 
dynamics. In a study by Brown et al. (2001), multiple strains of M. agassizii were found 
in Mojave desert tortoises, though differences in virulence corresponding with strain 





strains have also been detected by ribotyping in Mojave desert tortoises, with seemingly 
variable virulence corresponding with ribotypes (Snipes et al. 1995).  
In the last two decades, URTD has been extensively studied in Mojave desert 
tortoises and gopher tortoises, with no research focusing on the ecology of this disease 
across Gopherus species. The first larger study searching for M. agassizii and 
mycoplasmal URTD in Texas tortoises was only recently published (Guthrie et al. 2013), 
and found both the pathogen and antibodies to M. agassizii in tortoises in southern Texas. 
Regardless of decades of research focused on tortoise URTD, little is understood about 
the disease ecology and dynamics of URTD. The work presented in this dissertation 
answers questions on the ecology of URTD-associated pathogens through research at 
multiple spatial and ecological scales.  
This dissertation aims to address a few of the many questions involving URTD 
host-pathogen dynamics in tortoises, and will aid in our understanding of infectious 
disease ecology in long-lived ectotherms. To supplement studies on tortoise 
ecoimmunology associated with URTD, I use nasal flush samples to investigate microbial 
patterns, incorporating a range-wide study focused on Mojave desert tortoises and 
comparative studies discussing differences in the ecology of this disease among four 
tortoise host species.  
 
CHAPTER ONE OVERVIEW 
 Mojave desert tortoises inhabit a distribution in the Mojave and Colorado Deserts 
of the U.S. southwest. Through genetics, individuals of this species have been divided 





M. agassizii pathogen differs among the genotypes (Sandmeier et al. 2013). Chapter One 
analyzes prevalence and genetic diversity of M. agassizii in hundreds of nasal flush 
samples from wild-caught Mojave desert tortoises. Analyses in this chapter address the 
following questions: 
1) To add to recent diagnostic measures for URTD (Sandmeier et al. 2017), how 
does conventional PCR and Sanger sequencing compare with quantitative 
polymerase chain reaction (qPCR) methods? 
2) How prevalent is M. agassizii in local populations of Mojave desert tortoises, 
and how does prevalence differ among genotypes and local populations within 
genotypes? 
3) Can sequencing of three genetic markers of M. agassizii help us to 
differentiate strains and their relative virulence in Mojave desert tortoises? 
 
CHAPTER TWO OVERVIEW 
 The main goal of Chapter Two is to detect whether there are differences in the 
ecology of two species of Mycoplasma pathogens in different host species. Multiple 
pathogens are associated with URTD in Gopherus tortoises, and recently, a probe-based 
qPCR assay was developed to detect some of these pathogens (Braun et al. 2014). We use 
this assay to detect M. agassizii and M. testudineum in samples from four Gopherus 
tortoise host species, in addition to conventional PCR and DNA sequencing to detect 
genetic variation in M. agassizii to answer:  






2) What is the prevalence of each Mycoplasma pathogen, as well as prevalence 
of their co-infection, in each tortoise species, and do these frequencies vary 
among host species? 
3) Are clinical signs of URTD in the form of current or recent nasal discharge 
predicted by infection or co-infection of these Mycoplasma spp.? 
 
CHAPTER THREE OVERVIEW 
 In disease ecology, pathogens interact with each other and their host to affect the 
manifestation of disease. However, pathogens also interact within the microbial 
community within the host. Microbial interactions within a host span the range of 
positive, negative, and neutral interactions also found in communities of macro-
organisms. Little is known about the nasal microbiome within tortoise hosts. In the 
context of the tortoise upper respiratory tract, studies have assessed quantity and diversity 
of microbes present within the confines of culture-based methods (Dickinson et al. 2001, 
Ordorica et al. 2008). The influx of next-generation DNA sequencing techniques allows 
for more thorough and time-effective means of quantifying microbiomes.  
 In Chapter Three, my collaborators and I analyze microbiome data from 454-
pyrosequencing, a technique that has allowed us to detect nearly 20,000 bacterial 
operational taxonomic units in nasal flush samples representing four Gopherus tortoise 
species. Data from this assay are used to answer: 
1) What bacterial taxa are present in the noses of these tortoise hosts? 






3) Does the presence of URTD-associated bacteria affect community 
composition present in these samples? 
4) Are certain bacterial taxa predictably found in each tortoise species? 
5) How does the presence of nasal discharge affect bacterial diversity and 
community composition in the upper respiratory tract? 
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Upper respiratory tract disease (URTD), caused by Mycoplasma agassizii, has 
been deemed a threat to populations of Mojave Desert Tortoises, Gopherus agassizii. 
Previous work on URTD has focused on serology and visual health examinations to 
determine the extent of this disease in some natural tortoise populations. Here, we present 
the first range-wide study of the presence of the pathogen, M. agassizii, in Mojave Desert 
Tortoises. We detected M. agassizii in tortoise populations throughout the Mojave Desert, 
with notable differences in prevalence of M. agassizii among sampling sites within 
tortoise genotypes, and sampling years. Analyses of three genetic markers in the M. 
agassizii genome indicated very low nucleotide diversity and no relevant spatial 
structuring of Mycoplasma haplotypes. We use published lines of evidence to discuss the 
roles of rare transmission events and long-term mycoplasmal persistence in individual 
hosts on tortoise URTD dynamics. 
Key words: Chelonian; Disease; Host; Mycoplasma; Polymerase chain reaction; 
Quantitative PCR; Strain; Turtle; URTD 
 
INTRODUCTION 
DISEASES can have important effects on wildlife populations. When a pathogen is 
invasive and infects naïve host species and populations, such as the spreading of the 
fungus that causes chytridiomycosis (Batrachochytrium dendrobatidis), it can cause 
severe population declines in its amphibian hosts (Skerratt et al. 2007). Some host species 
can act as carriers, not directly affected by disease, but able to spread the pathogen to 





affect some individuals, while others are carriers, such as in the typhoid disease system in 
humans (reviewed in Merrell and Falkow 2004). 
An upper respiratory tract disease (URTD) caused by a species of Mycoplasma 
was first detected in Mojave Desert Tortoises, Gopherus agassizii (Cooper 1861), in 
California after a population crash in the late 1980s (Jacobson et al. 1991; reviewed in 
Sandmeier et al. 2009). This population crash was posited to be caused by URTD, and it 
spurred an abundance of research regarding the pathology (including mortality and 
morbidity) induced by the putative causative pathogen (Jacobson et al. 1991; Brown et al. 
1999). The population crash, as well as other population declines, led to the listing of 
Mojave Desert Tortoises as threatened under the Endangered Species Act in 1990 (U.S. 
Fish and Wildlife Service 1994). Brown et al. (1994) verified that the pathogen causing 
URTD was the newly named Mycoplasma agassizii (Brown et al. 1994, 2001). In 
tortoises, M. agassizii forms a close association with the nasal epithelium (Jacobson et al. 
1991), and URTD can cause clinical signs of nasal exudate, palpebral edema, and 
wheezing, with severe cases resulting in lethargy and potentially mortality (Brown et al. 
1994). Subsequent research continued to investigate the extent to which the disease 
threatens tortoise populations (Schumacher et al. 1997; Dickinson et al. 2005; Sandmeier 
et al. 2013) and resulted in the development of serological tools (ELISA and Western 
blot) that can be used to detect Mycoplasma antibodies in tortoises (Schumacher et al. 
1993; Brown et al. 2002; Hunter et al. 2008). Recently, a probe-based quantitative 
polymerase chain reaction for M. agassizii was developed and is used to detect the 






The ecological importance of URTD for tortoise populations continues to be 
controversial, because published reports have noted that this disease correlates with a 
high risk of morbidity, mortality, and population crashes (reviewed in Sandmeier et al. 
2009). It is currently thought that M. agassizii is present in tortoises throughout the 
Mojave Desert and prevalence, measured by serology, differs among geographic areas 
(Sandmeier et al. 2013). Additional data indicate that multiple strains of M. agassizii are 
present in Mojave Desert Tortoises (Brown et al. 2001), but the extent to which different 
strains are found in tortoise populations remains unknown. Until now, no study has 
comprehensively investigated the presence of M. agassizii in Mojave Desert Tortoises 
across their geographic range, from southern California to southwest Utah in the Mojave 
and Colorado Deserts. Furthermore, genetic variation within and among Mycoplasma 
populations has not been assessed. 
Here, we use samples of microbes obtained from nasal passages of Desert 
Tortoises to address the following questions: (1) What is the relative efficacy of 
conventional PCR and DNA sequencing compared with qPCR in detecting M. agassizii? 
(2) What is the prevalence of M. agassizii across the geographic distribution of Mojave 
Desert Tortoises? (3) Can different strains of M. agassizii be detected in our samples, and 
are certain strains more associated with clinical signs of disease in the tortoises than other 
strains? (4) Is prevalence of M. agassizii or disease correlated with tortoise genotype? We 
predict that M. agassizii is present in tortoise populations across the Mojave Desert, in 
accordance with previously measured seroprevalence (Sandmeier et al. 2013). We also 
predict that multiple strains of M. agassizii will be found, and that the presence of some 






The present study adds PCR and DNA sequencing to the diagnostic methods 
recently compared for their efficacy (Sandmeier et al. 2017). Additionally, we use the 
diagnostic methods presented here to answer broader questions regarding ecological 
patterns among the component parts of this disease system. 
 
MATERIALS AND METHODS 
Field Sites and Sample Collection 
Samples of upper respiratory bacteria were taken from wild-caught Mojave Desert 
Tortoises in the southwestern United States during the active season (April–October) 
between 2010 and 2012. Each tortoise was sampled only once. Our goal was to sample 
from sites relatively evenly spaced across the tortoise distribution (Fig. 1), and sites were 
generally delineated by mountain ranges, which confine tortoises to valley floors. Sites 
were selected to represent three previously determined tortoise genotypes: California 
(CA), Las Vegas (LV), and Northeast Mojave (NEM; Table 1; Hagerty and Tracy 2010). 
At most sites, tortoises are sparsely distributed (with home ranges ranging from 1–89 ha; 
Berish and Medica 2014); to increase the probability that our sampling was representative 
for each population, we found most tortoises along haphazardly selected 10 km transects. 
Approximately 1 tortoise encountered per 10 km transect can be expected based upon 
U.S. Fish and Wildlife surveys (available at 
https://psw.databasin.org/galleries/af8e55a0197a4c95a3120b278075a2b1), and our goal 
was to sample 20 tortoises per site. While tortoises can move long distances, they are not 





range that falls within a different genotype group. Thus, we used the assumed genotypes 
relevant for each local population as determined by Hagerty and Tracy (2010), and we 
did not verify genotype group per tortoise. Genotype was used to detect general patterns 
across the tortoise distribution. We additionally sought to mitigate biases in sampling 
among years by sampling sites during multiple years, when possible (Table 1). 
Visible presence of clinical signs of URTD, including nasal mucus or signs that 
the tortoise had recently exuded nasal discharge (occluded or asymmetrical nares, or 
eroded scales around nares), was evaluated for each tortoise. Tortoises with any of these 
signs of URTD were considered positive for clinical signs. Palpebral edema or any other 
ocular syndrome was not included in the list of relevant clinical signs of disease as they 
have not been included in the disease results from Koch’s postulates regarding M. 
agassizii and URTD (Brown et al. 1994). To determine whether Mycoplasma DNA was 
present in the upper respiratory tract, a nasal lavage sample was collected by flushing 3 
mL of sterile saline solution (0.9% NaCl) through the tortoise nares (Brown et al. 2002). 
Nasal lavage samples were immediately preserved in RNAlater Stabilization Solution 
(Ambion Inc., Austin, TX) at a ratio of 1:5 preservative to sample volume. Preserved 
samples were placed on ice in the field and frozen within 12 hr of collection. In the 
laboratory, DNA from 500 µL of preserved nasal lavage samples was extracted using the 
Qiagen DNeasy Blood and Tissue Kit (Qiagen Inc., Valencia, CA) protocol for gram-
negative bacteria. 
Mycoplasma Detection 
qPCR.—Presence of M. agassizii was detected by quantitative polymerase chain 





detect 50 copies of the 16S ribosomal RNA (rRNA) gene in M. agassizii with a Cq value 
of 38.5, maximum intra-assay variation of 0.97, and a detection limit of a Cq of 40 
(Braun et al. 2014). In qPCR, Cq value is a calculation of the number of cycles necessary 
for amplification of the desired region above a given threshold. Thus, a lower Cq 
corresponds to more of the desired template DNA in the sample. All qPCRs were 
conducted in triplicate with TaqMan Environmental Master Mix 2.0 using a Step One 
Plus Real-Time PCR System with 40 thermal cycles and Step One Software v2.3 
(Applied Biosystems, Foster City, CA). Following the recommendation of Braun et al. 
(2014), samples were considered to include the DNA of M. agassizii (qPCR-positive), if 
two or three of the triplicates had a Cq value below 40. 
Positive results were categorized as being either strongly positive (with a mean 
Cq < 38) or weakly positive (with 38 < mean Cq < 40). Although this qPCR assay can be 
used to detect the presence of M. agassizii in a sample up to a Cq value of 40, we divided 
qPCR results into three data sets in order to detect differences in patterns associated with 
strong versus weak infections: Data Set 1 (DS1) = both strongly positive and weakly 
positive samples were categorized as positive for M. agassizii, all other samples were 
categorized as negative; Data Set 2 (DS2) = only strongly positive samples were 
categorized as positive for M. agassizii, all other samples were categorized as negative; 
and Data Set 3 (DS3) = results from weakly positive samples were excluded from 
analyses, with only strongly positive samples categorized as positive and only negative 
samples categorized as negative. 
PCR.—Samples were screened for three M. agassizii genetic markers using PCR: 





(rpoB; see Table S1 in the Supplemental Materials available online). PCRs were 
conducted with Qiagen Multiplex PCR mix (Qiagen Inc.) with a 15-min hot start at 95°C 
and a final extension at 72°C. Nested and pseudo-nested PCR products of appropriate 
length were extracted from agarose gel using Qiagen QIAquick Gel Extraction Kit. Gel-
extracted products were sequenced at the Nevada Genomics Center on an ABI3730 DNA 
Analyzer (Applied Biosystems). Sequences were verified as M. agassizii using NCBI’s 
BLAST search (available at http://blast.ncbi.nlm.nih.gov). Samples were considered 
positive for M. agassizii if at least one PCR amplified the appropriate marker. 
qPCR and PCR Comparison.—Correspondence of M. agassizii results from 
qPCR and PCR assays per sample was assessed by calculating unweighted kappa 
statistics using the kappa2 function in the irr package (Gamer et al. 2010) in the 
programming language R (v3.2.1; R Core Team 2015). Cohen’s kappa (k) ranges from –
1.00 to 1.00, where values < 0.00 = poor agreement, 0.00–0.20 = slight agreement, 0.21–
0.40 = fair agreement, 0.41–0.60 = moderate agreement, 0.61–0.80 = substantial 
agreement, and 0.81–1.00 = almost perfect agreement (Landis and Koch 1977). PCR 
results were compared with the three qPCR data sets described above. 
Mycoplasmal Genetic Diversity and Geographic Structure 
DNA sequences were aligned in ClustalX v2.1 (Larkin et al. 2007) and trimmed 
in MEGA v6.06 (Tamura et al. 2013). Following Clement et al. (2000), TCS haplotype 
network analyses were conducted in PopART (Leigh and Bryant 2015). Haplotype 
networks included sequences from GenBank (available at http://www.ncbi.nlm.nih.gov) 
for M. agassizii (Accession numbers U09786.1, NR_114450.1, AY780802.1, 





and known strains, such as PS6 (Brown et al. 2001). Spatial analyses of molecular 
variance (SAMOVAs) were conducted separately for each marker in SAMOVA v1.0 
(Dupanloup et al. 2002) to detect spatial patterns of haplotypes. Sampling localities were 
input as the mean latitude and longitude coordinates of all tortoises sampled per site. 
SAMOVA was used to produce F-statistics by grouping sampling sites based upon their 
spatial coordinates and associated haplotypes. We ran SAMOVA with groups K = 2 to 16 
(when appropriate) and 100 simulated annealing processes (Dupanloup et al. 2002). The 
output having the highest Fct value (i.e., the number of groups that maximized among-
group variance relative to the total variance) defined the best number of groups. 
Sequences shorter than 75% of the average length for each genetic marker were excluded 
from haplotype analyses (excludes three samples for IGS and four samples for rpoB). 
Range-wide Prevalence 
Transmission of M. agassizii in adults is likely associated with social behaviors, 
and little is known about transmission or disease progression in juveniles. Thus, we chose 
to exclude possible confounding effects from juveniles by excluding four samples from 
tortoises smaller than 100 mm midline carapace length (MCL) from the range-wide 
analyses. One sample from the large-scale translocation site in Clark County, Nevada, 
was also excluded from further analyses because of ambiguities surrounding the 
historical origin of the tortoise. Analyses regarding genotypes included all remaining 
samples, while those regarding site-level patterns in prevalence exclude sites with fewer 
than ten samples assayed. 
Presence of Mycoplasma in nasal lavage samples (via qPCR) and clinical signs of 





using the glmer function in the lme4 and lmertest packages in R (Bates et al. 2015; 
Kuznetsova et al. 2016). Predictor variables included tortoise genotype, sampling year, 
sex, and MCL, with a random variable of site nested within genotype. Analyses of 
clinical signs of URTD also included Mycoplasma presence or Cq as a predictor variable. 
We used Tukey’s post-hoc tests to conduct pairwise comparisons to compare factors 
within the genotype, year, and sex variables by implementing the glht program in the R 
package multcomp (Hothorn et al. 2008). We analyzed Cq values using a linear mixed-
effects model with the lmer program in the lme4 package using the same predictor and 
random variables as for the analysis of Mycoplasma presence and Tukey’s post-hoc tests 
as above. To detect whether some sites differ in Mycoplasma presence from the rest of 
the genotype (Table 1), we analyzed Mycoplasma as predicted by site for each genotype 
with logistic regressions using the glm function. We compared average Cq values with 
Mycoplasma prevalence by site using linear regressions with the lm function in R to 
determine if higher average Mycoplasma loads tended to correspond with higher 
prevalence of Mycoplasma among sampling sites. 
 
RESULTS 
Sample Collection and Mycoplasma Detection 
Nasal lavage samples were collected from 402 wild Mojave Desert Tortoises from 
2010 to 2012. At least 10 tortoises were sampled from each of 21 sampling sites, and 
fewer samples were collected from six additional sites (Table 1, Fig. 1; and see Table S2 
in Supplemental Materials available online). Out of the 402 samples, PCR detected M. 





Detection of M. agassizii via PCR produced similar results with slight agreement 
to two qPCR data sets (DS2, n = 402, k = 0.159, P < 0.001; DS3, n = 315, k = 0.138, P < 
0.01; Table S3) in which the weakly positive samples were considered to be negative or 
excluded. The ĸ statistic between PCR and Data Set 1 was not significant (DS1, n = 402, 
k = 0.045, P = 0.23). 
Mycoplasmal Genetic Diversity and Geographic Structure 
The PCR reactions for 16S rRNA, IGS, and rpoB detected M. agassizii in 49, 51, 
and 26 samples, respectively. Nucleotide diversity of aligned, trimmed sequences was 
two to three times higher in IGS (47 samples, 352 bp, π = 0.0016) than rpoB (23 samples, 
548 bp, π = 0.0005) and 16S (47 samples, 453 bp, π = 0.0007). TCS network analyses for 
each genetic marker detected one principal haplotype, with additional haplotypes 
differentiated by one to three single-nucleotide polymorphisms, represented by a single 
sample (Fig. 2). A second haplotype was detected in five samples in the IGS marker (Fig. 
2b). Despite this shared secondary haplotype, SAMOVAs did not detect any meaningful 
spatial distribution of haplotypes for any of the three genetic markers, with or without the 
inclusion of indels in the analyses (Table S5; Fig. S1). Because each genetic marker 
resulted in one common haplotype, we could not determine whether uncommon 
haplotypes were more or less associated with clinical signs of disease. 
Range-wide Prevalence 
Tortoises with MCL ³ 100 mm were sampled from California (n = 156), Las 
Vegas (n = 106), and Northeast Mojave (n = 135) genotypes (Table 1). The following 





genotype, 57% of tortoises tested positive by qPCR for M. agassizii (Cq < 40), and 
Chuckwalla Bench had lower prevalence than other California sites (25%, t = –2.15, P = 
0.03; Fig. 3). Fifty-two percent of tortoises from the Las Vegas genotype had a detectable 
amount of M. agassizii. Of the sites within this genotype, Pahrump (25%, t = –3.141, P = 
0.002) and South Las Vegas (45%, t = –2.103, P = 0.04) samples had significantly lower 
levels of prevalence compared to other sites in the Las Vegas genotype, and prevalence in 
the Northwest Vegas site was marginally different (50%, t = –1.803, P = 0.07). In the 
Northeast Mojave (36% prevalence), Gold Butte, Mormon Mesa/Halfway, Red Cliffs, 
and Zion all stood out with significantly lower prevalence (P < 0.05). 
The GLMM did not detect effects of genotype, sex (female, n = 168; male, n = 
179; unknown sex, n = 47), or MCL on presence of M. agassizii (in all cases, P > 0.1). 
There was an effect of year on Mycoplasma presence, with 2011 having higher 
prevalence than 2010 (z = 2.354, P = 0.05), and marginally higher prevalence than 2012 
(z = –2.173, P = 0.08).  
Clinical signs of URTD (n = 91) were marginally correlated with presence of M. 
agassizii in nasal lavages (z = 1.879, P = 0.06), and were only predicted by sampling 
year, with 2010 having a lower occurrence than both other sampling years (2011, z = 
2.502, P = 0.03; 2012, z = 2.860, P = 0.01). When Mycoplasma presence was replaced 
with Cq value in the GLMM, Cq predicted presence of clinical signs (z = −1.948, P = 
0.05), with similar effects of sampling year. Thus, animals with more Mycoplasma per 
sample generally had an increased likelihood of exhibiting clinical signs of URTD.  
By site, there was a trend for the prevalence of M. agassizii to be negatively 





3.77, R2 = 0.17, P = 0.07; Fig. 4). Importantly, the Cq variable does not represent a linear 
change in starting quantity of target DNA, but rather the number of PCR cycles necessary 
to reach a threshold. Thus, a decrease in Cq by 3.5 is associated with an approximately 
ten-fold increase in target DNA. Cq values from our sample DNA ranged from 28.98 in a 
sample from Ord Rodman to 39.93 in a sample from Gold Butte, representing a 1000-fold 




From the kappa statistics, we found that PCR and qPCR provided similar 
diagnostic value on the scale of the individual host. The best agreement between these 
techniques occurred when weakly positive samples were considered to be negative, 
indicating that qPCR might be more sensitive than PCR. Further supporting this notion 
was the observation that most of the disagreement between the two techniques resulted 
from positive qPCR results corresponding with negative PCR results (20–40%, 
depending on the data set), whereas we detected up to 14.7% negative qPCR results 
corresponding with positive PCR results (Table S3). In addition to lower detection 
sensitivity, PCR and DNA sequencing is expensive and time-consuming compared to 
qPCR. Thus, as a diagnostic technique to detect this pathogen in nasal lavage samples 
from tortoises, we recommend qPCR over PCR, interpreting Cq values under 40 as 
positive for M. agassizii, as suggested in Braun et al. (2014). Although our previous work 
detected higher intra-assay variability at Cq values of 38 and above (Sandmeier et al. 





increase more than Type I errors at low DNA concentrations. Thus, even Data Set 1 
could underestimate true prevalence of the microbe (Sandmeier et al. 2017), especially 
considering the imprecision of the nasal lavage sampling process. 
Mycoplasmal Diversity 
We sequenced three genetic markers of M. agassizii from Mojave Desert 
Tortoises and found very little genetic variation. The type strain of this pathogen (PS6) 
was cultured from a Mojave Desert Tortoise and had similar rpoB and IGS sequences to 
the mycoplasmas collected in our study, but its 16S rRNA sequence differed slightly 
from the main haplotype that we detected (Fig. 2). This type strain (PS6) is considered to 
be especially pathogenic (Brown et al. 1994, 2001), and the fact that it differs from the 
rest in 16S rRNA could indicate that the pathogen has evolved since its first discovery, or 
that we did not sample tortoises in areas where the type strain originally occurred (e.g., 
Desert Tortoise Natural Area, Kern County, CA). Importantly, this pathogenic strain was 
not detected in our survey. 
The three genetic markers that we sequenced are in conserved regions of the 
genome or linked to conserved regions. In a previous report, multiple strains that differed 
in physical size and cell viability after storage were found in the host species (Brown et 
al. 2001). Whereas we did not find evidence of distinct, shared strains, the true 
determinant of genetic differentiation requires genome-level analyses of isolates from 
field samples. A better understanding of the M. agassizii genome could allow for 
identification of virulence factors, such as adhesins, which might be an important 
indicator of virulence at a population level of the host. If there are virulence factors 





seem most at risk based on the Mycoplasma strains present. With this kind of 
information, managers could better address the implications of tortoise translocation 
programs and the potential effects of habitat-altering stressors on disease outbreaks at a 
local population scale. 
Range-wide Patterns 
Mycoplasmal URTD in Mojave Desert Tortoises is categorized by slow 
transmission and slow disease progression (Maloney 2011; Aiello et al. 2016). Previous 
work by Jacobson et al. (1995) found that tortoises appearing to be healthy could in fact 
be infected, and it is possible that an infection is not detectable by field techniques that 
preserve the tortoise’s life. Although histology is the best determination of URTD 
(Jacobson et al. 1995), it is not a practical method to determine population-level disease 
and infection patterns in a threatened species. Whereas we detected samples that were 
qPCR-negative for M. agassizii, many more of our cultured field samples contained M. 
agassizii, even though its presence was not detected by pre-culture qPCR (C.L. 
Weitzman, personal observation). Thus, it is important to note that many more 
individuals likely harbor this pathogen than can be detected. 
Although there is a downward trend in population sizes over most of the Mojave 
Desert Tortoise distribution (U.S. Fish and Wildlife Service 2015), since the crashes of 
1989–1990 (Corn 1994; Peterson 1994), we know of only one crash in the mid 1990s, 
seemingly caused by drought (Longshore et al. 2003; reviewed in Sandmeier et al. 2009). 
Mycoplasma agassizii is widespread across its host’s distribution, but to the best of our 
knowledge, no die-offs have been linked to disease in the last 25 yr, despite locations 





prevalence paired with low morbidity and mortality rates supports the hypothesis that this 
pathogen maintains colonies in the tortoise host, becoming infective at higher loads that 
could be triggered by environmental stressors or interactions within the upper respiratory 
microbiome. 
We found that the presence of M. agassizii was associated with clinical signs of 
disease in individual tortoises, supporting previous findings of a similar correlation at the 
population level (Sandmeier et al. 2017). This correlation was tighter when only strongly 
positive samples were included in the pool of those positive for M. agassizii (Data Sets 2 
and 3), indicating that a higher pathogen load might be more likely to cause URTD. Low 
pathogen loads might be attributable to recent colonization; alternatively, pathogen load 
could oscillate between high and low levels, with similar cycles in morbidity. 
Currently, it is unknown how M. agassizii persists in hosts in a subclinical state. 
While M. agassizii is an extracellular pathogen that binds to the epithelium of its host 
(Jacobson et al. 1991), some predominantly extracellular mycoplasmas can also survive 
and reproduce within host cells, including M. pneumoniae, M. penetrans, M. genitalium, 
M. gallisepticum, and M. fermentans (Dallo and Baseman 2000; Rosengarten et al. 2000; 
Waites and Talkington 2004). It seems that this pattern of life-history traits might be 
common among Mycoplasma species. Hosts of M. pneumoniae might spread the 
pathogen without experiencing morbidity, and the presence of a carrier state might 
explain the cyclical epidemic trends in M. pneumoniae that occur every 3–5 yr (reviewed 
in Waites and Talkington 2004). Possibly, M. agassizii also has an intracellular stage or 
hides elsewhere in the respiratory tract of the host, where sampling cannot reach. 





easily represented in lavage samples. The presence of infection cycles in this host-
pathogen system could explain the differences that have been observed in M. agassizii 
prevalence among years and sites. Sandmeier et al. (2013) found higher serological 
prevalence in the Northeast Mojave tortoise genotype than in the California genotype, but 
our sampling for Mycoplasma by qPCR years later did not reveal a similar pattern. The 
large time delay between serological and pathogen assays could have allowed for cycling 
of disease dynamics, explaining why patterns from the serological survey did not 
correspond with similar patterns in the present pathogen survey. Additionally, if serology 
and pathogen presence are not correlated on a local population scale (sampling locality) 
at a single time point (see Sandmeier et al. 2017), then cyclical patterns in URTD-
associated variables might also explain these discrepancies. Alternatively, tortoise 
immune responses to similar loads of M. agassizii could vary among populations, 
possibly caused by differences in thermal environment or nutrition (Sandmeier et al. 
2013; Drake et al. 2016). 
Most disease models focus on parameters of pathogen transmission. We propose 
that this tortoise/Mycoplasma system might be unique in the interplay between 
persistence in a long-lived host and rare transmission events. There are currently no 
available data on the recovery of tortoises from URTD, as the progression of this disease 
is extremely slow. If an individual host cannot clear itself of the pathogen, then even a 
low transmission rate could allow M. agassizii to accumulate across entire populations of 
Desert Tortoises, as this host species exhibits a long life-span and low turnover of adults 
(2%; U.S. Fish and Wildlife Service 1994). If that is the case, then predictive models 





Lastly, it is important to note that pathogens other than M. agassizii are also 
associated with respiratory disease in Gopherus tortoises. Mycoplasma testudineum is 
another causative agent of URTD in Desert Tortoises (Jacobson and Berry 2012). 
Pasteurella testudinis and a herpes virus are also associated with tortoise respiratory 
disease (Snipes et al. 1980; Snipes and Biberstein 1982; Jacobson et al. 2012). 
Mycoplasmas can be present in co-infections in tortoises and other vertebrate species 
(Salinas et al. 2011; Ley et al. 2012), yet we know neither the extent to which co-
infections of URTD-associated pathogens occur in Gopherus tortoises, nor the 
importance of co-infections in the development from sub-clinical to clinical disease. 
Although M. agassizii can cause URTD (Brown et al. 1994), it is possible that in wild 
tortoise populations, an interaction among pathogens is required before clinical signs of 
disease are detected. 
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FIGURE 1. Sampling sites of Gopherus agassizii from 2010–2012. Colors denote tortoise 
genotype (following Hagerty and Tracy 2010): California = blue, Las Vegas = green, 













FIGURE 2. TCS haplotype networks for three genetic markers of Mycoplasma agassizii. 
Circle sizes are based on number of individuals in the haplotype. Colors denote tortoise 
genotype (following Hagerty and Tracy 2010): California = blue, Las Vegas = green, 
Northeast Mojave = orange, GenBank sequences = black. (a) 16S rRNA; (b) 16-23S 
intergenic spacer: of the GenBank sequences, PS6 shares the common haplotype and 
Karina09 is separated by one single-nucleotide polymorphism from the secondary 









FIGURE 3. Prevalence of Mycoplasma agassizii at 21 sites in the Mojave Desert where at 















FIGURE 4. Average Cq value as a function of qPCR prevalence of Mycoplasma agassizii 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table S3. Sample-level comparison of PCR and qPCR results. Data Set 1 – all Cq values 
categorised as positive, all other samples are negative; Data Set 2 – only strongly positive 
samples (Cq < 38) are categorised as positive for M. agassizii, all other samples are 
categorised as negative; Data Set 3 – results from weakly positive samples (Cq > 38) are 
excluded from analysis, with only strongly positive samples (Cq < 38) categorised as 
positive and only samples with no Cq value categorised as negative. Cohen’s kappa (k) 
and p-values from calculated unweighted kappa statistics. 
 
  
qPCR Data Set 1 qPCR Data Set 2 qPCR Data Set 3 
k = 0.0453, P = 0.23 k = 0.159, P < 0.001 k = 0.138, P < 0.01 
+ − + − + − 
PCR + 38 30 30 38 30 30 





Table S4. Sites represented in SAMOVAs for each genetic marker. 
Site 16S rRNA IGS rpoB 
Chuckwalla Bench yes yes yes 
Coyote Springs yes yes yes 
Fenner Valley yes yes no 
FISS yes no no 
Gold Butte yes yes no 
Ivanpah yes yes yes 
Kelso Wash yes yes no 
Laughlin yes yes no 
Mormon Mesa yes yes no 
North Coyote Springs yes yes yes 
NW Vegas yes yes yes 
Ord Rodman yes yes yes 
Pahrump yes yes yes 
Piute no yes no 
Red Cliffs yes yes no 
River Mtn. Valley yes yes yes 
S. Las Vegas yes yes yes 
Shadow Valley yes yes yes 
 
Table S5. Optimal number of groups of sampling sites from SAMOVAs, and site 
groupings associated. Sites not listed are each assigned individual groups.  
SAMOVA Optimal K Group 1 Group 2 Group 3 










NW Vegas   
IGS 2 
[Piute is alone, 
remaining are 
grouped together] 








North Coyote Springs 





North Coyote Springs 




Figure S1. F-values from SAMOVA 1.0 with trimmed haplotypes with and without 
indels. Colors indicate F-statistics: Fsc = purple, Fst = orange, Fct = green. a/b) 16S 
without and with indels; c/d) 16-23S intergenic spacer without and with indels; e/f) rpoB 
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In disease ecology, the host immune system interacts with the environmental 
conditions of the host and properties of the pathogen(s) to affect the impact of disease on 
the host. Within the host, pathogens also may interact to facilitate or inhibit each other’s 
growth. In addition, pathogens interact with different hosts in different manners, allowing 
some individuals to be carriers of pathogens that can cause great harm to others. We 
investigated co-infection patterns of two Mycoplasma pathogens (M. agassizii and M. 
testudineum) and the association of infection with clinical signs of disease in four 
congeneric tortoise host species (Gopherus) in the United States as a means to detect 
differences in infection risk and disease dynamics in these species. Mojave desert 
tortoises had greater prevalence of M. agassizii than both Texas tortoises and gopher 
tortoises, while there were no differences in M. testudineum prevalence among the host 
species. Patterns of sole infection and co-infection were statistically similar among host 
species. In some, but not all host species, the presence of each pathogen influenced the 
infection intensity of the other pathogen species. Hence, these two pathogens of 
Mycoplasma interact differently within different hosts. Neither infection, nor co-
infection, were associated with clinical signs of disease. To detect strain variation, which 
may influence disease outcome if strains have variable pathogenicity, we sequenced three 
genetic markers of M. agassizii and detected no meaningful differentiation of haplotypes 
among host species. Experimental inoculation studies, as well as recurrent resampling of 
wild individuals, could help to decipher the underlying mechanisms of disease dynamics 





Key words: co-infection, disease ecology, Gopherus, Mycoplasma, parasite, quantitative 
PCR, Testudinidae, turtle, URTD 
 
INTRODUCTION 
 The manifestation of disease depends on interactions between the host and 
pathogen, in relation to the environment of the host. Pathogens can directly or indirectly 
affect other pathogens when co-infecting a host, and these microbial interactions can, in 
themselves, positively or negatively affect the survival of each pathogen within the host 
(e.g., Telfer et al. 2010). Mutualistic, commensalistic, or neutral interactions of pathogens 
within a host can result in additive or synergistic rates of clinical signs of disease. 
Alternatively, co-infection of pathogens that interact with each other negatively could 
result in disease with lower impact than what is expected additively.  
 Species in the tortoise genus Gopherus range from the Mojave Desert in the 
western United States to the longleaf pine forests of the southeastern U.S., with different 
tortoise species inhabiting distinct vegetative ecosystems and climates. Four Gopherus 
spp. are found in the United States: Mojave desert tortoises, Gopherus agassizii; Sonoran 
desert tortoises, G. morafkai; Texas tortoises, G. berlandieri; and gopher tortoises, G. 
polyphemus, which are broadly distributed in the southeastern U.S. Additionally, multiple 
pathogens are known to be associated with URTD in Gopherus, including Mycoplasma 
agassizii, M. testudineum, Pasteurella testudinis, an iridovirus, and Testudinid 
herpesvirus 2 (Snipes et al. 1980, Snipes and Biberstein 1982, Brown et al. 1994, 2004, 
Westhouse et al. 1996, Jacobson et al. 2012). Thus, there is potential for different 




by different host species. Previous studies have detected upper respiratory tract disease 
(URTD), and pathogens known to cause this disease, in each of the four tortoise species 
found in the U.S. (Jacobson et al. 1991, Judd and Rose 2000, Diemer Berish et al. 2000, 
Jones 2008, Guthrie et al. 2013). Nevertheless, the majority of research on URTD has 
focused on M. agassizii. 
Population declines in Mojave and gopher tortoises have been hypothesized to be 
caused by URTD, although the actual impacts of this disease to individuals and 
populations remains controversial (McCoy et al. 2007, Sandmeier et al. 2009). 
Understanding disease dynamics in this system is especially important as both the 
Mojave desert tortoise (U.S. Fish and Wildlife Service 1994) and the gopher tortoise in 
the western portion of its range (U.S. Fish and Wildlife Service 1990) are listed as 
threatened under the Endangered Species Act of 1973. 
 Here, we report on the prevalence of two pathogens in the tortoise-URTD system 
(M. agassizii and M. testudineum) in the four tortoise species within the U.S. to establish 
whether the occurrence or co-infection of these pathogens affects the manifestation of 
clinical signs of disease differently among hosts. We use nasal flushes to sample nasal 
microbes and visual observations of clinical signs of disease to answer: 1) Are there 
genetically different bacterial types of the pathogen M. agassizii among tortoise species? 
2) At what frequencies are the pathogens M. agassizii and M. testudineum, both 
individually and in co-infection, present in local tortoise populations among tortoise 
species? 3) Does the presence or co-infection of these pathogens predict the presence of 





Sampling and DNA Extraction 
We used a 3 mL saline (0.9% NaCl) nasal lavage (Brown et al. 2002; Weitzman 
et al. in press) to sample upper respiratory Mycoplasma from four species of wild-caught 
Gopherus tortoises. Nasal lavage samples were immediately preserved in RNAlater 
stabilization solution (Ambion Inc., Austin, Texas, USA) at a ratio of 1 part sample to 5 
parts preservative volume. Samples were placed on ice in the field and frozen within 12 
hours. Each tortoise was sampled once, providing a snapshot of disease and pathogen 
patterns. All tortoises were captured by hand, except for gopher tortoises, which 
generally were trapped either with a pitfall trap or other live trap. While handling each 
tortoise, we recorded midline carapace length (MCL) and clinical signs of URTD. 
Clinical signs were scored based on severity: 0 = no signs; 1 = wheezing breath and/or 
damaged scales around nares; 2 = occluded nares; 3 = serous discharge from nares; 4 = 
purulent discharge from nares; 5 = nasal exudate and deeply damaged nares; 6 = nasal 
exudate and poor body condition (Sandmeier et al. 2017). Data on clinical signs were not 
available for 13 sampled Texas tortoises. We used secondary sex characteristics (Goin 
and Goff 1941, Woodbury and Hardy 1948) to determine the sex of sampled tortoises in 
all adults. Juveniles were classified as animals without clear secondary sex characteristics 
and were, on average, 40–60% the average adult size. 
Using the Qiagen DNeasy Blood and Tissue Kit (Qiagen Inc., Valencia, 
California, USA) protocol for gram-negative bacteria, we extracted DNA from 500 µL of 
preserved lavage sample. We conducted polymerase chain reaction (PCR) for three 




region (IGS), and ribosomal polymerase beta subunit (rpoB); Weitzman et al. in press) to 
detect genetic variation of this pathogen among tortoise species. PCR products of 
appropriate length were extracted from agarose gel using the Qiagen QIAquick Gel 
Extraction Kit and sequenced at the Nevada Genomics Center with an ABI3730 DNA 
Analyzer (Applied Biosystems, Foster City, California, USA). Sequences were identified 
as Mycoplasma using NCBI’s BLAST search (http://blast.ncbi.nlm.nih.gov). 
Differentiation of Mycoplasma agassizii Among Gopherus spp. 
A TCS haplotype network (Clement et al. 2000) was made for each of the three 
genetic markers from amplified sequences using PopART (Leigh and Bryant 2015). 
Sequences were aligned in ClustalX 2.1 (Larkin et al. 2007) and trimmed in MEGA6 
(Tamura et al. 2013). Because sequences were of varying length, haplotype networks 
only included sequences at least 75% of the average length for each genetic marker. M. 
agassizii sequences from GenBank (http://www.ncbi.nlm.nih.gov) were included in 
haplotype networks for all markers (type strain PS6 (Brown et al. 2001) from a Gopherus 
agassizii individual: Accession numbers U09786.1, AY780802.1, EU925153.1). 
Additional laboratory sequences from the ATCC strain 723 cultured from a Gopherus 
polyphemus were included in the haplotype networks for 16S rRNA and IGS.  
Infection and Co-Infection Analyses 
We used a multiplex quantitative PCR (qPCR) protocol for M. agassizii and M. 
testudineum to detect both pathogens (Braun et al. 2014). qPCRs were repeated in 
triplicate for each sample with thresholds determined by serial dilution curves. Samples 
that amplified in at least two reactions with a Cq value under 40 were considered positive 




We used generalized linear models to detect differences in prevalence of M. 
agassizii and M. testudineum among tortoise species. Tukey’s post-hoc tests evaluated 
pairwise differences between tortoise host species. Analyses were run in the 
programming language R using the multcomp package for post-hoc analyses (version 
3.2.1; Hothorn et al. 2008, R Development Core Team 2015). 
Samples were assigned the following infection codes based on qPCR results: 0 = 
neither M. agassizii nor M. testudineum detected, 1 = positive for M. agassizii only, 2 = 
positive for M. testudineum only, or 3 = positive for both Mycoplasma spp. 
We used the multinom function in the nnet package (Venables and Ripley 2002) 
to conduct multinomial logistic regressions of sex and species or site to predict infection 
codes and Tukey’s post-hoc tests to evaluate differences among groups in the lsmeans 
package (Lenth 2016). We corrected for the error rate due to false discovery in 
multinomial logistic regression post-hoc tests using the Benjamini Hochberg method, 
with a false discovery rate of 0.05, allowing for a highest significant p-value of 0.0183 
(Benjamini and Hochberg 1995, Benjamini and Yekutieli 2001).  
To help determine under what circumstances hosts contract disease, we used 
generalized linear models to detect whether host sex, site, and infection code significantly 
predict the presence of clinical signs for each host species. We used linear models to 
detect a correlation of infection intensity between the two Mycoplasma spp. (using Cq 







We sampled 256 tortoises between 2010 and 2015, including three geographic 
sampling sites for each species (Table 1, Figure 1). We used PCR with Sanger 
sequencing to detect genetic diversity of three markers in the M. agassizii genome, and 
we detected M. agassizii in 27 samples using this method (16S rRNA: n = 9; 16-23S 
intergenic spacer: n = 19; rpoB: n = 9). We produced TCS haplotype networks from these 
data (Figure 2), which did not suggest clear differentiation of M. agassizii populations 
among tortoise host species. In two Mycoplasma genetic markers (16S rRNA and rpoB), 
this microbe is only represented from two of the four tortoise hosts sampled. 
Using a probe-based qPCR assay (Braun et al. 2014), we detected M. agassizii in 
92 samples and M. testudineum in 65 samples, ranging in prevalence across the tortoise 
host species (Figure 3). In generalized linear models, host species differed in prevalence 
of M. agassizii: desert tortoise species had higher prevalence than Texas tortoises (P < 
0.001 each), and Mojave desert tortoises had higher prevalence than gopher tortoises (z = 
–4.768, P < 0.001). Prevalence of M. testudineum did not differ by host species (P > 0.4 
each; Figure 3). In Texas tortoises, every individual with detectable M. agassizii was also 
co-infected with M. testudineum (Figure 3). Infection load of each pathogen was 
relatively low (average Cq of 37.5±1.52 (s.d.) for M. agassizii, 37.2±1.80 for M. 
testudineum), and Cq values ranged from 30.9 to 39.9, representing an approximately 
200–500 fold increase (depending on the pathogen) from the lowest to the highest load 
detected. These high Cq values indicate a generally low infection load of either pathogen. 
Of the samples positive for Mycoplasma, only 6 (M. testudineum) or 7 (M. agassizii) 




For the following analyses, tortoise samples were categorized into four infection 
groups from qPCR results: 0 = neither Mycoplasma detected; 1 = M. agassizii detected; 2 
= M. testudineum detected; 3 = both Mycoplasma spp. detected. Presence of these 
infection groups were analyzed using multinomial logistic regressions. In pairwise 
comparisons, all host species significantly differed in patterns of these infection groups 
(P < 0.015 each). 
Mojave desert tortoise infection 
A similar amount of Mojave desert tortoise samples were either uninfected or 
infected with just M. agassizii, and fewer samples had a single infection of M. 
testudineum or co-infection of both species of Mycoplasma (Table 1). Tortoises from 
Eldorado Valley had lower prevalence of M. testudineum in sole infection versus co-
infection. More individuals in Fenner Valley had a sole infection of M. agassizii than M. 
testudineum or co-infection of both mycoplasmas. In Red Cliffs tortoises, lack of 
infection was more frequent than sole infection with M. testudineum. 
Infection types were similarly represented in juvenile Mojave desert tortoises (n = 
5), while in both adult males and females, M. agassizii infection rate was greater than M. 
testudineum infection (Table 2).  
Sonoran desert tortoise infection 
 Regarding infection in Sonoran desert tortoises, more individuals were uninfected 
by either Mycoplasma than infected with one or both pathogens. In Cave Buttes, 
prevalence of either pathogen in sole infection was lower than absence of infection 
(Table 1). Infection prevalence of any type was significantly lower than frequency of no 




prevalence of sole infection between the two Mycoplasma spp., with higher prevalence of 
M. agassizii. 
Juvenile Sonoran desert tortoises (n = 2) did not have detectable infection. In 
females, more individuals were uninfected than infected with just M. testudineum, while 
frequency of the remaining infection groups were statistically similar. In males, absence 
of infection was more frequent than all other infection groups (Table 2). 
Texas tortoise infection 
 In Texas tortoises, no individuals had M. agassizii as a sole infection, and absence 
of any infection was more common than presence of M. testudineum or co-infection 
(Table 1). At Chaparral WMA, no samples were positive for M. agassizii, and thus no 
individuals had co-infection of both Mycoplasma spp., but presence and absence of M. 
testudineum occurred at similar rates. Tortoises from East Rio Grande had M. 
testudineum infection less frequently than no infection, and at West Rio Grande, absence 
of infection was more frequent than either M. testudineum infection or co-infection 
(Table 1). 
A similar number of juvenile Texas tortoises (n = 13) had co-infection, M. 
testudineum infection, and no infection (Table 2). In adults, however, absence of either 
pathogen was more frequent than co-infection, and females were also more likely to have 
no infection than M. testudineum infection alone. 
Gopher tortoise infection 
 Pairwise comparisons in gopher tortoises discovered significantly more 
individuals with an absence of infection than any other infection status (Table 1). At 




group. In Perdido tortoises, prevalence of M. agassizii in sole infection was higher than 
prevalence of M. testudineum. At the University of South Florida site, absence of 
infection was more frequent than sole infection with either Mycoplasma, but not more 
frequent than co-infection (Table 1).  
In female gopher tortoises, infection rate of any type was significantly lower than 
no infection. In males, infection rate of M. testudineum was lower than absence of 
infection, and sole infection of either Mycoplasma occurred at lower rates than absence of 
infection in juveniles (Table 2). 
Clinical Signs of Disease 
From generalized linear models, none of the infection groups significantly 
predicted the presence of clinical signs of URTD for any host species, and most of the 
tortoises with clinical signs of disease did not have detectable amounts of either M. 
agassizii or M. testudineum in their upper respiratory tracts (P > 0.1; Figure 4). In gopher 
tortoises, we found that individuals from the University of South Florida site had 
significantly lower rates of clinical signs of URTD than Perdido tortoises (USF 3%, 
Perdido 28%, Tukey’s post-hoc, z = –2.408, P = 0.041).  
Although we found clinical signs of disease in the form of nasal discharge or 
tissue damage from recent discharge in each of the four tortoise species, none of the 
Texas or Sonoran desert tortoises sampled had nasal mucus present at the time of 
sampling. Rather, clinical signs of disease in those species manifested as eroded scales 
around the nares or occluded nares (severity score 1–2). Serous nasal mucus (severity 
score 3) was found in gopher (n = 3) and Mojave desert (n = 6) tortoises at the time of 




mucus (severity score 5), and we did not detect either species of Mycoplasma in her 
lavage sample. 
Inter-Pathogen Associations 
A greater M. agassizii load (lower Cq value) was correlated with the presence of 
M. testudineum in tortoise noses (F(1,90) = 5.49, P = 0.02). This relationship was likely 
driven by its significance in the Mojave desert tortoise (F(1,37) = 6.428, P = 0.016; Figure 
5a). Because all Texas tortoises with detectable M. agassizii also had M. testudineum, we 
could not compare differences in M. agassizii load between presence and absence of M. 
testudineum. 
Within all host species combined, the presence of M. agassizii in nasal lavage 
samples was marginally associated with less M. testudineum (F(1,63) = 3.859, P = 0.054), 
though in gopher tortoises, more M. testudineum was correlated with the presence of M. 
agassizii (F(1,18) = 4.447, P = 0.049; Figure 5b). 
Finally, an increase in amount of either bacterium correlated with an increase in 
amount of the other species (F(1,39) = 7.39, P = 0.0097; Figure 5c). However, no host 




We detected both Mycoplasma agassizii and M. testudineum in all four tortoise 
species inhabiting the United States. These pathogens have been reported to cause upper 
respiratory tract disease (URTD) in tortoise hosts, and some have hypothesized that 




(Brown et al. 1994, 1999, 2004, Seigel et al. 2003, Sandmeier et al. 2009, Jacobson et al. 
2014). We aimed to decipher the evolutionary history of this pathogen and detect the 
bacterial strain diversity within and among host populations with sequences of three 
genetic markers of M. agassizii. Multiple strains of M. agassizii have been found in 
Mojave desert tortoises (Brown et al 2001), but no efforts have since been made to 
determine the variation of Mycoplasma diversity within and among hosts. If some strains 
are more associated with disease than others, then relevant host populations could be 
appropriately managed. However, we did not detect any meaningful differentiation of this 
pathogen among its tortoise hosts. Because our current understanding of the M. agassizii 
genome lies in its conserved regions, we suggest that genomic data of these bacteria 
would allow us to determine bacterial strain diversity within and among host populations, 
and potentially to discover the relative virulence of strains. However, variable virulence 
can also occur with minimal genetic diversity (Razin et al. 1998). Even clonal 
mycoplasmas can present high diversity of surface antigens through phenotypic plasticity 
(Razin et al. 1998). Infection of mycoplasmas by viral phages can also impact the 
bacteria’s pathogenicity (Razin et al. 1998). Furthermore, diversity of tandem repeat 
sections of the genome can allow for increased chromosomal rearrangement and phase 
variation in the cell surface antigens of Mycoplasma (Razin et al. 1998). 
 Thus far, the focus of research regarding URTD has been on the pathogen M. 
agassizii, even though URTD in tortoises is also associated with M. testudineum, 
Pasteurella testudinis, an iridovirus, and Testudinid herpesvirus 2 (Snipes et al. 1980, 
Snipes and Biberstein 1982, Westhouse et al. 1996, Brown et al. 2004, Jacobson et al. 




results did not detect an infection or co-infection status that best associated with the 
presence of clinical signs of disease (Figure 4). In disease systems, there is an incubation 
period between colonization of the nasal passages and the onset of clinical signs (and the 
ability to transmit pathogens). Frequently, there is an assumption that the presence of 
clinical signs of disease, such as nasal discharge, is associated with shedding of bacteria, 
enabling disease spread; more often than not, we were unable to detect either 
Mycoplasma in samples collected from tortoises with clinical signs of disease (Figure 4). 
Half (5/10) of the tortoises exhibiting nasal discharge at the time of sampling did not 
have detectable amounts of either pathogen in their lavage samples. Thus, while these 
pathogens or their interactions with yet additional pathogens may be the cause of disease, 
the presence of nasal discharge may be a necessary, but clearly not sufficient, variable in 
the spread of Mycoplasma. 
Little is known about the prevalence or progression of infections in juvenile 
Gopherus tortoises. Recent research by Aiello et al. (2016) found that, on average, long 
periods of direct nose-to-nose contact are required for M. agassizii to be transmitted 
between adult Mojave desert tortoises. It seems that burrow-sharing at night is the most 
likely means of exposure, and reproductive Mojave desert tortoises are the most likely 
individuals to interact with conspecifics via burrow sharing or using multiple different 
burrows (Sah et al. 2015). Previous research has also reported disease in sub-adults, even 
though its spread is associated with social interactions attributed to adults (Schumacher et 
al. 1997, Wendland et al. 2010). We included pre-reproductive tortoises in the present 
study and found infection by both mycoplasmal pathogens in young individuals of each 




ruled out, research has shown that vertical transmission is unlikely for M. agassizii 
(Schumacher et al. 1999) and has not been studied for M. testudineum. Gopherus can 
reach sexual maturity in their teens (Germano 1994), and thus they have many years to 
interact with others before the onset of social interactions associated with mating. 
Juvenile desert tortoises do occasionally share burrows with adult tortoises (Bulova 
1994), as do juvenile gopher tortoises with other juveniles (Radzio et al. 2016), and the 
extremely low likelihood of Mycoplasma surviving in burrow soil (Orlowski et al. 2015) 
suggests that direct contact is required for pathogen transmission. A recent study found 
that aggressive behaviors lead to contact between juveniles (Radzio et al. 2016). 
Additional research examining pre-reproductive behaviors of tortoises that allow them to 
become infected would greatly help in our understanding of transmission of pathogens 
associated with URTD. Importantly, we suspect that these Mycoplasma species, as in 
other systems, may have life-long, chronic, cyclical interactions with their tortoise hosts 
(Weitzman et al. in press). If this is the case, the rate of infection in young tortoises may 
be an important factor in the prevalence and dynamics of these pathogens among local 
host populations. 
Our analyses suggest that Mojave desert tortoises are more likely than other 
tortoise species to have detectable amounts of M. agassizii in their upper respiratory 
tracts. Local populations of Mojave tortoises are declining range-wide, and understanding 
threats by pathogens is important for management initiatives. When tortoises are 
translocated as part of management schemes, knowing the pathogen prevalence in the 
source and destination populations could be critically important in predicting survival of 




hypothesized to cause population declines via host mortality, it seems more likely that 
under normal conditions, infected tortoises will be minimally harmed, with a chronic 
latent infection (Sandmeier et al. 2009). However, if disease severity increases as a 
consequence of environmental stressors, then factors such as habitat alterations and a 
changing climate could compound to influence the disease trajectory in hosts, as is the 
case in other systems (Acevedo-Whitehouse and Duffus 2009). Gopherus tortoises can 
live for up to 80 years, and individuals reproduce throughout adulthood, with low adult 
mortality rates (U.S. Fish and Wildlife Service 1994). Some local populations are likely 
more at risk due to disease than others (Tuma et al. 2016). For the long-term management 
of Mojave desert tortoises, focus should be placed on minimizing stressors to decrease 
the risk of exacerbating the severity of URTD, as stronger infection loads have been 
linked to higher risk of transmission (Aiello et al. 2016). URTD can also lower the 
reproductive success of adult females, and high prevalence of URTD in reproductive 
females might significantly reduce recruitment, contributing to tortoise population 
declines (Rostal et al. 1996). 
Interestingly, while we detected mild clinical signs of disease in Sonoran and 
Texas tortoises, none of the tortoises examined exhibited mucus discharge. This suggests 
that mycoplasmal pathogens might interact differently with different host species. 
Variance in disease dynamics among host populations occurs in other host-pathogen 
systems, such as with the fungus Batrachochytrium dendrobatidis (Bd) in frog species. 
Among frog species, some experience very high morbidity and mortality rates due to 
chytridiomycosis, the disease caused by Bd, while others are carriers, unaffected by the 




morbidity due to chytridiomycosis do so along a spectrum of harm (Kilpatrick et al. 
2010). The four tortoise species in our study experience different ecological interactions 
in different ecosystems, so we should not assume that pathogens affect these host species 
similarly. In the Texas tortoise, M. agassizii was only detected in co-infection with M. 
testudineum. Future research should determine whether or not this pattern persists within 
larger samples and at different sites within the Texas tortoise distribution. None of the 
Texas tortoises sampled (n = 56) had nasal discharge present at the time of sampling, 
even though URTD has been detected in this species, particularly in captive individuals 
(Judd and Rose 2000). As most research on this disease has focused on gopher and 
Mojave desert tortoises, further studies should determine how pathogens that cause 
URTD in other tortoise hosts affect species for which this disease system is less well 
understood. 
The interactions between pathogens within a host could be facilitative, 
competitive, antagonistic, or neutral. Telfer and colleagues (2010) investigated the range 
of interactions among four pathogens infecting locations throughout a vole host species 
and found a wide range of positive and negative interactions. The type and strength of 
interactions were not necessarily reciprocal and depended on recency and whether an 
infection was acute or chronic. In our data, while the presence of each pathogen affected 
the infection intensity of the other (Figure 5), this pattern was not consistent across host 
species. These results indicate that the two pathogens might facilitate each other in a 
context-dependent manner, and that these pathogens interact differently with their hosts 





Here, we provide a snapshot view of Mycoplasma prevalence in four North 
American tortoise species. While we have data on co-infection rates between 
Mycoplasma spp., we still lack prevalence data on other associated pathogens in the 
system. From preliminary pyrosequencing data, we have found Pasteurella testudinis in 
50–92% of samples tested from the same four tortoise species (Weitzman et al. in prep). 
A probe-based qPCR approach to assay for P. testudinis would enable us to add a piece 
to the puzzle to best determine how pathogens interact to cause URTD. 
 In our study system, two Mycoplasma pathogens are present in differing co-
infection patterns depending on the host species. Our data suggest a low amount of 
genetic variation in M. agassizii among four allopatric host species that span the two 
coasts of the United States. Furthermore, a majority of the tortoises sampled with clinical 
signs of URTD did not have detectable amounts of either Mycoplasma in their nasal 
lavage samples. The two species with lower pathogen prevalence, gopher tortoises and 
Texas tortoises, had greater prevalence of clinical signs than the other species sampled 
(Figures 3, 4). These results suggest that long-term data, assaying for additional 
pathogens, and monitoring environmental stressors might be necessary to understand 
more fully the role of each pathogen type in the cause and severity of disease. Recurrent 
resampling of individuals and assaying for all known pathogens would provide a more 
thorough view of pathogen dynamics over time, and an artificial experiment study on co-
infections would disentangle how these pathogens interact within their hosts. 
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TABLE 1. Sample size in each Gopherus tortoise species and geographic sampling site, 
with relative proportion of each infection/co-infection result. Mycoplasma spp. infection 
are values outside of co-infection. Letters next to proportions denote significant 
differences within species or site. Results are from Tukey’s post-hoc tests of multinomial 















TABLE 1. Sample size in each Gopherus tortoise species and geographic sampling site, 
with relative proportion of each infection/co-infection result. Mycoplasma spp. infection 
are values outside of co-infection. Letters next to proportions denote significant 
differences within species or site. Results are from Tukey’s post-hoc tests of multinomial 
logistic regressions at a significant probability level of 0.0183. 
Species, Site n No Infection M. agassizii M. testudineum Co-infection 
G. agassizii 57 0.28 a 0.44 a 0.04 b 0.25 a 
   Eldorado 17 0.12 ab 0.18 ab 0.06 a 0.65 b 
   Fenner 19 0.16 ab 0.74 a 0.05 b 0.05 b 
   Red Cliffs 21 0.52 a 0.38 ab 0.00 b 0.10 ab 
G. morafkai 51 0.53 a 0.25 b 0.02 b 0.20 b 
   Cave Buttes 8 0.50 a 0.13 b 0.13 b 0.25 ab 
   Silverbell 18 1.00 a 0.00 b 0.00 b 0.00 b 
   Sugarloaf 25 0.20 ab 0.48 a 0.00 b 0.32 ab 
G. berlandieri 56 0.68 a 0.00  0.23 b 0.09 b 
   Chaparral WMA 30 0.63 a 0.00  0.37 a 0.00 b 
   East Rio Grande 13 0.62 a 0.00  0.08 a 0.31 a 
   West Rio Grande 13 0.85 a 0.00  0.08 b 0.08 b 
G. polyphemus 92 0.64 a 0.14 b 0.09 b 0.13 b 
   Perdido 29 0.69 a 0.24 b 0.00 b 0.07 b 
   Rayonier 32 0.69 a 0.03 b 0.19 b 0.09 b 











TABLE 2. Sample sizes for each sex per Gopherus tortoise species, with proportions of 
each infection result. Mycoplasma spp. infection are values outside of co-infection. 
Letters denote significant differences within each row at a significant probability level of 















each infection result. Mycoplasma spp. infection are values outside of co-infection. 
Letters denote significant differences within each row at a significant probability level of 






Figure 1. Sites sampled representing three geographic locations for each of four tortoise 
species: Red = Gopherus agassizii, Mojave desert tortoises; Orange = G. morafkai, 
Sonoran desert tortoises; Green = G. berlandieri, Texas tortoises; Blue = G. polyphemus, 
gopher tortoises. FV = Fenner Valley; ED = Eldorado Valley; RC = Red Cliffs; CB = 
Cave Buttes; SL = Sugarloaf; SB = Silverbell; CH = Chaparral Wildlife Management 
Species, Sex n No Infection M. agassizii M. testudineum Co-infection 
G. agassizii          
   Female 25 0.24 ab 0.40 a 0.04 b 0.32 ab 
   Male 27 0.30 ab 0.48 a 0.04 b 0.19 ab 
   Juvenile 5 0.40 a 0.40 a 0.00 a 0.20 a 
G. morafkai          
   Female 26 0.38 a 0.35 ab 0.04 b 0.23 ab 
   Male 23 0.65 a 0.17 b 0.00 b 0.17 b 
   Juvenile 2 1.00 a 0.00 b 0.00 b 0.00 b 
G. berlandieri          
   Female 30 0.70 a 0.00  0.23 b 0.07 b 
   Male 14 0.64 a 0.00  0.29 ab 0.07 b 
   Juvenile 12 0.67 a 0.00  0.17 a 0.17 a 
G. polyphemus          
   Female 46 0.63 a 0.17 b 0.07 b 0.13 b 
   Male 31 0.58 a 0.16 ab 0.13 b 0.13 ab 




FIGURE 1. Sites sampled representing three geographic locations for each of four tortoise 
species: Red = Gopherus agassizii, Mojave desert tortoises; Orange = G. morafkai, 
Sonoran desert tortoises; Green = G. berlandieri, Texas tortoises; Blue = G. polyphemus, 
gopher tortoises. FV = Fenner Valley; ED = Eldorado Valley; RC = Red Cliffs; CB = 
Cave Buttes; SL = Sugarloaf; SB = Silverbell; CH = Chaparral Wildlife Management 
Area; WE = West Rio Grande; EA = East Rio Grande; PD = Perdido River; RY = 












FIGURE 2. TCS haplotype networks of Mycoplasma agassizii. Colors based on host 
species or culture sequence: Red = Gopherus agassizii, Orange = G. morafkai, Green = 
G. berlandieri, Blue = G. polyphemus, Black = Culture sequences (from GenBank or in-
lab sequencing). Each square represents a single sequence. a) 16S ribosomal RNA with 
trimmed sequences 468 bp in length. GenBank sequence for type-strain PS6 split from 
the main haplotype, while the in-lab sequence for ATCC strain 700617 from a gopher 
tortoise grouped with the main haplotype. b) 16-23S intergenic spacer region, sequences 
476 bp in length. GenBank sequence for PS6 grouped with the core haplotype, while the 
in-lab sequence for ATCC strain 700617 separated from the core haplotype by two single 
nucleotide polymorphisms. c) Ribosomal polymerase beta subunit sequences of 568 bp in 





FIGURE 3. Barplot of prevalence of Mycoplasma agassizii (light grey), M. testudineum 
(stripes), and co-infection of the two Mycoplasma spp. (dark grey) by host species. 
Letters above M. agassizii bars denote significant differences in prevalence of that 
pathogen between the host species from Tukey’s post hoc tests on a generalized linear 






FIGURE 4. Stacked bar plot of infection groups split by presence of clinical signs of 
disease in each Gopherus tortoise host species. Colors denote infection group, with 
lighter shades indicating absence of clinical signs of disease: Purple = no infection; Blue 
= M. agassizii sole infection; Green = M. testudineum sole infection; Red = co-infection 
of both Mycoplasma. In G. berlandieri, 13 tortoises were not evaluated for clinical signs, 






FIGURE 5. Presence and infection intensity (Cq as a proxy) of each Mycoplasma species 
based on the other. a) Mycoplasma agassizii with and without M. testudineum in 
Gopherus agassizii (Mojave desert tortoises; F(1,37) = 6.428, P = 0.016); b) M. 
testudineum in samples with and without M. agassizii in G. polyphemus (gopher tortoises; 
F(1,18) = 4.447, P = 0.049); c) Correlation of Cq values between the two Mycoplasma spp. 
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 Astoundingly rich and diverse bacterial communities are found on every surface 
of macro-organisms, and they play important roles in maintaining normal physiological 
functions in their hosts. While the study of microbiomes has expanded with the influx of 
data enabled by next-generation DNA sequencing technologies, microbiome research in 
reptiles is lagging behind other organisms. We sequenced the nasal microbiome in four 
North American tortoise species, and we found differing community compositions among 
tortoise species and geographic sampling sites, with higher richness in Texas and 
Sonoran desert tortoises. Using the microbiome data, we investigated the prevalence and 
OTU diversity of the potential pathogen Pasteurella testudinis within and among tortoise 
species, and found it to be common, abundant, and highly diverse. However, the presence 
of this bacterium was not associated with a change in bacterial community composition. 
We also found that the presence of nasal discharge from tortoises at the time of sampling 
was associated with a decline in nasal microbiome species richness and a change in 
microbiome composition, which we posit is due to the harsh epithelial environment 
associated with upper respiratory disease. Repeated sampling across seasons, and at 
different points of pathogen colonization, should contribute to our understanding of the 
causes and consequences of different bacterial communities in the nasal passages of these 
long-lived hosts. 
 






The influx of next-generation DNA sequencing technology has allowed the study 
of community ecology to delve more effectively beyond the focus of macro-organisms 
into the world of the microscopic. As in communities of macro-organisms, members of 
microbial communities participate in positive, negative, and neutral interactions with 
other community members. Furthermore, microbial taxa interact with the larger 
organisms in or on which they reside. Many microbiome studies have been discovery-
based, focusing on the identification of microbial species and their location on a host. Gut 
microbes, and their roles in evolutionary transitions between carnivory and herbivory, 
have been especially well represented in the literature. A recent review of non-
mammalian microbiome studies found that most reptilian studies fail to address 
microbiomes other than those related to the gut (Colston and Jackson 2016).  
Microbiomes may be particularly important for understanding infectious diseases. 
In disease ecology, characteristics of the host, its environment, pathogens, and their 
interactive effects are synthesized to discuss the manifestation of disease. Recently, 
Hanson and Weinstock (2016) proposed to add the microbiome as a fourth node to the 
disease ecology triangle, emphasizing the role of the microbial community in determining 
the way a pathogen harms its host. Epidemiological studies, particularly those involving 
human diseases (Hanson and Weinstock 2016), but also some wildlife diseases, consider 
the role of microbiomes increasingly more frequently. One such disease garnering recent 
attention is chytridiomycosis, a pandemic affecting amphibian hosts caused by fungal 
pathogens.  The skin of amphibians harbors microbial communities that can inhibit 




antimicrobial abilities of a host’s microbiome could greatly impact whether an invading 
pathogen succeeds in the host. Conversely, when fungal pathogens are able to invade 
amphibian skin, the composition of the skin microbial communities may be altered (Jani 
and Briggs 2014). 
While the microbiome of amphibian skin has been at the forefront of emerging 
disease research, the microbiomes associated with other herpetofaunal diseases have been 
largely neglected thus far. One disease that could benefit from more microbial 
community research is an upper respiratory tract disease (URTD), associated with 
bacterial and viral pathogens, which is found in North American tortoise species. The 
tortoise genus Gopherus includes six species, four of which are found in the southern 
portion of the U.S. mostly in allopatric habitats: Mojave desert tortoise (G. agassizii) in 
the southwest (California, Nevada, Utah, Arizona); Sonoran desert tortoise (G. morafkai) 
in the southwest (Arizona into Mexico); Texas tortoise (G. berlandieri) in Texas and into 
Mexico; and gopher tortoise (G. polyphemus) in the southeast (Florida, Georgia, South 
Carolina, Alabama, Mississippi, and Louisiana). In these tortoises, multiple pathogens are 
associated with URTD, including Mycoplasma agassizii, M. testudineum, Pasteurella 
testudinis, an iridovirus, and testudinid herpesvirus 2 (Snipes et al. 1980, Snipes and 
Biberstein 1982, Brown et al. 1994, Westhouse et al. 1996, Brown et al. 2004, Jacobson 
et al. 2012). This respiratory disease causes nasal exudate and lesions on the nasal 
epithelium, with extreme cases resulting in lethargy or even death (Brown et al. 1994). It 
is likely that pathogen proliferation in tortoise hosts occurs after an environmental 
stressor, affecting the host’s immune system or causing a shift in microbial community 




The study of URTD has focused on detecting relevant pathogens, visually 
detecting signs of disease, and using serological tools to determine exposure to pathogens 
(Schumacher et al. 1997, Brown et al. 2001, Hunter et al. 2008, Jones 2008, Sandmeier et 
al. 2013, Guthrie et al. 2013). In Mojave desert tortoises (Gopherus agassizii), few 
studies have addressed the upper respiratory tract microbial community, and those that 
have used labor-intensive culturing methods. Dickinson et al. (2001) detected 19 taxa in 
nasal and cloacal samples from desert tortoises, while Ordorica et al. (2008), found 260 
bacterial isolates in the nasal passages of desert tortoises. In the present study, we use 
next-generation DNA sequencing technology to determine not only the members of 
tortoise upper respiratory microbiomes, but also to search for patterns of microbial 
community structure. We compared upper respiratory tract microbial communities in four 
congeneric Gopherus tortoise species to test the following hypotheses: (1) Microbes 
associated with URTD are found in microbial communities with different compositions 
from those without pathogens; and (2) The presence of nasal mucus correlates with 
differing microbial communities from those in tortoises without nasal mucus. We also 
use the microbiome data to evaluate the population diversity of one potential pathogen of 
interest, Pasteurella testudinis. 
 
METHODS 
DNA Collection and Microbiome Sequencing 
We sampled upper respiratory bacteria from all four species of Gopherus found in 
the U.S. using a 3 mL nasal lavage (0.9% NaCl; Brown et al. 2002, Weitzman et al. in 




additional sites for Mojave desert tortoises to address patterns regarding the presence of 
nasal mucus (Table 1). Nasal lavage samples were immediately preserved in RNAlater 
Stabilization Solution (Ambion Inc., Austin, Texas, U.S.) at a ratio of 1:5 preservative to 
sample volume, placed on ice in the field, and frozen within 12 hours of sampling. We 
extracted the DNA from lavage samples with the Qiagen DNeasy Blood and Tissue Kit 
(Qiagen Inc., Valencia, CA, U.S.). Amplification of the variable regions V1-V3 of the 
bacterial 16S ribosomal RNA gene with the 28F/519R primer set and subsequent 454-
pyrosequencing were conducted at the Research and Testing Laboratory (Lubbock, TX, 
U.S.).  
Using methods described in Braun et al. (2014), we conducted qPCRs to 
determine the presence or absence of the URTD-causing pathogens Mycoplasma 
agassizii and M. testudineum in our samples, which have been analyzed elsewhere 
(Weitzman et al. in prep, F. C. Sandmeier unpublished data). 
The following analyses were conducted using the QIIME bioinformatics pipeline 
(Caporaso et al. 2010), with default parameters, unless otherwise stated. Where 
applicable, we used unweighted Unifrac distance matrices (Lozupone and Knight 2005).  
After quality filtering and demultiplexing, we clustered operational taxonomic 
units (OTUs) using an open-reference OTU-picking process, which clusters sequences 
based on 97% similarity and identifies taxonomy using the GreenGenes database 
(DeSantis et al. 2006, Edgar 2010, McDonald et al. 2012). We subsetted the resultant 
OTU table separately to compare patterns among the four host species and among 





Bacterial Communities Among Host Species 
We compared patterns of upper respiratory bacterial communities among tortoise 
species using data from three sampling sites per species, excluding data on Mojave desert 
tortoises from South Las Vegas and Red Cliffs (Table 1). OTUs were filtered to exclude 
those represented by only one sequence, and to exclude those identified as mitochondrial, 
as well as Chloroplast, indicating plant origin. The resulting dataset included 19,163 
OTUs from 24 to 11950 sequences per individual sample (2784 ± 2234 s.d.).  
Because OTU richness was correlated with the number of sequences per sample 
(Figure 1a), we compared the residuals of this correlation among species and sites using 
ANOVA and Tukey’s post-hoc HSD tests in the programming language R (R 
Development Core Team 2015). To detect differences in bacterial community 
composition among species and sites and based on the presence of Mycoplasma spp., we 
rarefied data to 1000 sequences per sample and conducted analyses of similarity 
(ANOSIMs) with 999 permutations. 
Using the pyrosequencing results, we wanted to determine whether Pasteurella 
testudinis, a possible pathogen in Gopherus tortoises (Snipes and Biberstein 1982) was 
present in each sample. Gregerson et al. (2009) published a study separating the genus 
Chelonobacter from that of Pasteurella, identifying Chelonobacter sp. as a pathogen of 
European tortoises, sister taxon to Pasteurella testudinis present in North American 
tortoise species. Although the reference database used in the present study, GreenGenes 
(DeSantis et al. 2006, McDonald et al. 2012), has data on both genera, OTUs in our 
analyses were identified as being within the Chelonobacter genus. Another method of 




sequences as P. testudinis. Because the identification method used in this study did not 
identify any additional sequences as P. testudinis, and because only a small DNA 
sequence was used to determine taxonomic identity, we analyze and discuss 
Chelonobacter with the assumption that it is, in fact, the P. testudinis bacterium 
previously found in North American tortoises.  
To compare communities with and without this microbe, the data were trimmed to 
exclude Chelonobacter OTUs and we conducted principal coordinates analysis and 
ANOSIMs on rarefied 500 sequences per sample. Furthermore, we used pairwise 
ANOSIMs to compare the OTUs identified as being in the genus Chelonobacter by 
producing an OTU table containing only sequences from this genus. 
The core microbiome is the group of bacterial types present in most or all 
(depending on cut-off percentage) of the samples in a group. We computed the core 
microbiome OTU composition for each tortoise species and each site separately. Lastly, 
we applied supervised learning to determine the predictability of bacterial communities 
among tortoise hosts by using an algorithm to predict host species identity based on its 
bacterial community (Knights et al. 2011). Supervised learning was run after excluding 
OTUs represented by fewer than 20 sequences and rarefying to 1000 sequences per 
sample. 
Disease Signs in Mojave Desert Tortoises 
Because zero Texas and Sonoran desert tortoises had nasal discharge at the time 
of sampling, and few gopher tortoises had discharge, we sequenced the microbiomes 
from tortoises with and without visible mucus in Mojave desert tortoises sampled in 




filtered to exclude singletons and OTUs that were likely derived from plant tissue in the 
tortoise nares and mitochondria, as above. Data from Coyote Springs and Eldorado were 
excluded in these analyses, as no individuals from those sites had nasal discharge at the 
time of sampling.  
To determine whether the presence or absence of nasal discharge was associated 
with differing levels of OTU richness, we compared residuals from a linear model 
between OTU richness and the total number of sequences using an ANOVA in program 
R. Beta diversity, comparing diversity between samples, was evaluated with ANOSIM 
and principal coordinates analysis on unweighted Unifrac distances. Diversity of 
Chelonobacter populations was also compared between samples from tortoises with and 
without nasal mucus using ANOSIM. 
 
RESULTS 
Pyrosequencing resulted in 24-11950 sequences in any one sample, totaling 
19,644 bacterial OTUs represented by >1 sequence over all samples.  
Comparisons of Bacterial Communities Among Tortoise Hosts 
Samples from three sites per tortoise species contained an average of 2784 
sequences. In each tortoise species, bacteria in the phyla Proteobacteria, Actinobacteria, 
Firmicutes, and Bacteroidetes collectively amounted to 84% to 94% of the rarefied 
sequences (Figure 2a). Ten bacterial classes represented at least 5% of sequences for any 
one sampling location (Figure 2b). The class Gammaproteobacteria accounted for >25% 
of OTUs in all host species except Texas tortoises.  




sample (Figure 1a; F(1,133) = 31.57, P < 0.0001), and residuals of that regression were 
significantly different among host species, with Texas and Sonoran desert tortoises 
supporting higher OTU richness than gopher and Mojave desert tortoises (pairwise 
Tukey’s HSD, P < 0.015 each; Figure 1b). Within tortoise species, sites had similar OTU 
richness, one exception being that Sonoran desert tortoises from Sugarloaf had higher 
richness in comparison to those from Silverbell (pairwise Tukey’s HSD, P = 0.0006; 
Figure 1c). 
When data were rarefied to 1000 sequences per sample, 29 samples were 
excluded (Mojave desert tortoise, n = 13; Sonoran desert tortoise, n = 8; Texas tortoise, n 
= 6; gopher tortoise, n = 2). Pairwise ANOSIMs detected significantly different 
communities among all tortoise host species (P = 0.001 each; Figure 3a). Sites sampled 
within tortoise species also hosted significantly different microbiota (ANOSIMs, P £ 
0.002 each). The presence of Mycoplasma agassizii was correlated with different 
bacterial communities in Mojave and Sonoran desert tortoises (G. agassizii, R = 0.2433, 
P = 0.014; G. morafkai, R = 0.102, P = 0.046), but this was not the case in Texas or 
gopher tortoises (ANOSIMs, P ³ 0.9 each). Presence or absence of M. testudineum was 
not associated with differing microbiomes in any tortoise host species (ANOSIMs, P > 
0.06 each). 
To compare bacterial communities with and without Pasteurella testudinis, we 
made the assumption that OTUs identified as genus Chelonobacter represented P. 
testudinis (see methods; Gregerson et al. 2009). We excluded Chelonobacter sequences 
to compare bacterial communities with and without this microbe for each host species 




with and without Chelonobacter (ANOSIMs, P > 0.07 each in Mojave, Sonoran, and 
Texas tortoises). Only three gopher tortoise samples were negative for this possible 
pathogen, and while they seem to separate in principal coordinates space, more samples 
without Chelonobacter are needed to verify this pattern.  
A total of 268 OTUs were identified as Chelonobacter across all species of hosts. 
Chelonobacter comprised up to 98% of the bacterial sequences in a sample (gopher 
tortoise from Rayonier; including 31 OTUs) with up to 84 different Chelonobacter OTUs 
detected per sample (Sonoran desert tortoise from Sugarloaf). Chelonobacter populations 
were only significantly different between Texas and Sonoran desert tortoises (ANOSIM, 
R = 0.1592, P = 0.001; Figure 3c).  
The purpose of a core microbiome analysis is to determine which OTUs are 
present in many or most individuals of a group, possibly allowing us to detect potentially 
ecologically important taxa. The presence of a core microbiome varied widely by host 
species. In Mojave desert tortoise samples, only one OTU was present in 50% of the 
samples (a Pseudomonas), while 50% of Texas tortoise samples shared 41 OTUs, one of 
which (Dietzia) was found in 90% of the samples. Core microbiomes (50% cut-off) for 
gopher and Sonoran desert tortoises each included 30 OTUs. The number of OTUs found 
in 75% of samples from each site also varied, from one in Coyote Springs samples 
(Mojave desert tortoise) to 26 in East Rio Grande samples (Texas tortoise; Figure 4). 
Four Chelonobacter OTUs were common in samples from gopher tortoises (all three 
sites) and Sonoran desert tortoises from Sugarloaf. Core microbiota (75% cut-off) from 
Sugarloaf, Perdido, and University of South Florida shared three Chelonobacter OTUs, 




an additional type not common in samples from any other site. One Chelonobacter OTU 
was found in all samples from the University of South Florida reserve (gopher tortoise).  
We ran a supervised learning algorithm to determine the likelihood of identifying 
host species based on bacterial community association. Supervised learning, excluding 
rare OTUs and run with 1000 sequences per sample, resulted in perfect or near perfect 
assignment for gopher tortoise and Texas tortoise communities (<5% error rate), though 
the error rates for assigning the bacterial communities in the two desert tortoises to the 
correct hosts were higher (13% Mojave desert tortoises; 25% Sonoran desert tortoises).  
Interaction with Clinical Signs of Disease 
In Mojave desert tortoises, the presence of exuded nasal mucus at the time of 
sampling was associated with a decrease in OTU richness in lavage samples (Figure 5a; F 
= 16.26, P = 0.0006). Samples from tortoises with mucus also had significantly different 
bacterial community composition than those from tortoises without mucus (R = 0.376, P 
= 0.002; Figure 5b). This pattern was observed whether all sequences were included in 
analyses or samples were rarefied to 500 sequences. Therefore, we present the full 
analysis because the smaller subset of data discards four of the nine samples from mucus-
positive tortoises. We analyzed Chelonobacter populations between tortoises with and 
without secretions of nasal mucus and found no difference between the two groups (R = -
0.0039, P = 0.387).  
 
DISCUSSION 
Tortoise Upper Respiratory Microbiome 




microbial diversity, community composition, and core microbiome in the nares of four 
North American tortoise species in the context of an upper respiratory tract disease and 
its associated bacterial pathogens. Our four tortoise species, and sites sampled within 
those species, had significantly different bacterial communities (Figure 1,3). 
Accordingly, we did not find strong core microbiomes for each tortoise species, 
particularly for the two species of desert tortoise, and site-level core microbiomes varied 
in size across the sampling locations (Figure 4).  
We used a Unifrac distance metric to assess beta diversity in our samples 
(Lozupone and Knight 2005). This metric uses phylogenetic distance to characterize 
community differences. The spread of principal coordinates values from Unifrac 
distances (Figure 3) suggests a high diversity of bacterial types capable of surviving in 
these varied tortoise host environments. Further research should address the degree to 
which microbial community composition or diversity is influenced by both abiotic and 
biotic environmental conditions for the host, such as rainfall, and transmission among 
tortoises. Moreover, we do not know if the patterns that we found are stable through time 
or space, and we know little about how nasal microflora change across the seasons 
(sampling in this study was not restricted to the same season), with no studies addressing 
changes over the course of a host’s lifetime. Using culturing techniques, Ordorica et al. 
(2008) found changes in total bacteria count between seasons, with higher counts in the 
summer versus autumn. They also found that tortoises with clinical signs of URTD had 
larger and more diverse upper respiratory communities, opposite to what we found in the 
present study (Figure 5a). 




while gopher tortoises inhabit forests of the southeastern United States, experiencing 
frequent rainfall events and less seasonality. Differences found among Sonoran tortoise 
bacterial communities (Figure 3) could be a result of sampling time, as tortoises were 
sampled after the beginning of the monsoon season, though they also inhabit a dry 
environment. The lack of a strong core microbiome in the two desert tortoise species 
could mean that those hosts act more like distinct islands, with little opportunity for 
movement of upper respiratory-associated bacteria among individual hosts. Thus, in 
desert tortoise species, microbiomes may function as isolated communities rather than as 
large contiguous metapopulations of associated bacteria. 
Interestingly, the tortoise species most studied with regard to social structure and 
social interactions, the gopher tortoise (Guyer et al. 2014), had a more widespread range 
of bacterial community composition, visualized in principal coordinates space, than 
Mojave desert tortoises or Texas tortoises. However, gopher tortoises did have a stronger 
core microbiome than Mojave desert tortoises. We currently do not know if these 
differences are a function of social structure or host physiology, or if they are affected by 
the environment of the host or an artifact from sample sizes of three sites per tortoise 
species. Burrow sharing and other social interactions could increase the similarity in the 
upper respiratory microbiome, as such activities may aid in the direct transmission of 
upper respiratory pathogens (Bulova 1994, Wendland et al. 2010, Aiello et al. 2016).  
In our samples, care was not taken to avoid bacteria that would be associated with 
the face, particularly the scales around the nares, as these samples were collected for 
other studies regarding disease ecology in tortoises. Thus, some taxa found in the present 




maintained in the tortoise respiratory tract. Although there have been no published 
reports on skin-associated bacteria in reptiles (Colston and Jackson 2016), we predict that 
because reptile skin is not a mucus membrane, the skin microbiome would be more 
similar to the environment than that found in amphibians. In sympatric amphibian 
species, cutaneous bacterial community composition is tightly linked to species identity 
(McKenzie et al. 2012, Kueneman et al. 2014). If our upper respiratory tract data were 
strongly influenced by skin and environmental bacteria, then the additional bacteria 
should increase the presence of a core microbiome, a result not supported in our data. 
Nevertheless, we acknowledge that a portion of our sequencing results likely includes 
transient taxa or bacteria found only in close proximity to the upper respiratory tract, but 
not necessarily maintained in it. 
Similar to the skin microbiome in many other taxa (Avena et al. 2016), the 
majority of OTUs from the upper respiratory tracts of tortoises were in the bacterial phyla 
Proteobacteria, Actinobacteria, Firmicutes, and Bacteroidetes. These phyla, plus 
Fusobacteria, are also commonly found in human upper respiratory tracts (de 
Steenhuijsen Piters et al. 2015), with Bacteroidetes and Firmicutes dominating human 
lung bacteria (Dickson et al. 2016). Actinobacteria, however, comprised a greater 
percentage of Sonoran desert tortoise (19%) and Texas tortoise (27%) bacteria than that 
found on the skin of other non-human animals. 
In North American tortoises, microbiome research involving next-generation 
sequencing technology has also been conducted on the fecal gut microbiome in gopher 
tortoises in Florida. Yuan et al. (2015) discovered over 1000 core OTUs found in at least 




microbiome in the gut versus the lack of strong core microbiome found in our nasal 
samples is likely due to different roles played by the microbiome in different regions of 
the body, as well as different methods used to describe the host microbiome. Tortoises 
are herbivorous hind-gut fermenters, requiring a gut microbiome with large responsibility 
in the process of food digestion. The nasal flora, alternatively, likely play a role in disease 
avoidance (Wilson and Hamilos 2014). Furthermore, data collected by Yuan et al. (2015) 
used Illumina MiSeq data, a sequencing platform that results in a higher sequence count 
than the pyrosequencing conducted here. MiSeq technology allows for an increase in 
sequencing speed, resulting in a higher sequence count and lower cost. The role of the 
microbiome in respiratory mucosal immunity, a field still nascent in human immunology, 
influences whether or not we should expect to find a looser relationship between a 
tortoise and its nasal microbiome than with its gut microbiome.  
On epithelial tissue, microbes are important for mucosal homeostasis (McDermott 
and Huffnagle 2014), in addition to their role in stimulating the immune system, resulting 
in greater immunocompetence in organisms with a healthy microbiome than those with 
an altered or absent microbial community (Brown and Clarke 2016). Microbes in the 
digestive tract also play an important role in digestion, a task not required by the 
respiratory tract. Importantly, microbes in any one mucosal location do not have effects 
limiting to that location, and gut microbes can aid in fighting off respiratory pathogens 
(Brown and Clarke 2016). As most research focuses on the importance of gut microbes, 
the importance of respiratory bacteria, particularly outside of the context of human 




Associations with Pathogens and Disease 
Studies of URTD in North American tortoises have focused on Mycoplasma 
pathogens, with little research on the presence or effects of Pasteurella testudinis in the 
tortoise host. When P. testudinis was first described, multiple strains were found among 
different locations in the tortoise host, and this pathogen was described as being usually 
commensal with healthy tortoise hosts, though capable of causing disease (Snipes and 
Biberstein 1982). Furthermore, within P. testudinis isolated from the upper respiratory 
tracts of Mojave desert tortoises, there is some differentiation between types more or less 
associated with URTD (Snipes et al. 1995). In our analyses, we assume that what was 
identified as Chelonobacter represented P. testudinis (see methods; Gregerson et al. 
2009), though further research should better distinguish between these two genera. 
The amount of diversity in our samples in the genus Chelonobacter was 
extremely large, though a previous study also found high ribotype diversity of this 
pathogen in tortoises (Snipes et al. 1995). Three Chelonobacter OTUs were common and 
shared among gopher tortoises and Sonoran tortoises from Sugarloaf. Chelonobacter 
populations were similar among most host species studied, indicating that this bacterium 
and its genotypic diversity are widespread in North American tortoises. Mojave desert 
tortoises with and without nasal mucus did not have differing Chelonobacter populations, 
suggesting that if this pathogen is associated with disease, then a variable beyond 
bacterial strain is likely the cause of disease progression. Furthermore, the presence of 
Chelonobacter in the microbiome did not impact the remaining bacterial community 
composition.  




Mycoplasma agassizii associated with differing bacterial communities. This result 
indicates that different strains could be present in different tortoise host species, the 
pathogen interacts differently with the different hosts, affecting the bacterial communities 
in differing ways, or some other aspect of the ecology of this mycoplasma in its bacterial 
community differs among hosts. Where M. agassizii is associated with a shift in 
microbiome community, it is possible that tortoise hosts are colonized with Mycoplasma 
without disease-causing impacts until the community is pushed away from equilibrium 
by a stressor, with the shift in microbiome allowing Mycoplasma to switch from a 
commensal organism to one that causes URTD.  
Our data on Mojave desert tortoises additionally found that nasal exudate was 
associated with a decrease in bacterial diversity (Figure 5a) and a change in the bacterial 
community composition (Figure 5b). If nasal exudate is a sign of upper respiratory tract 
disease, then it is also associated with lesions, inflammation, and sloughing off of 
mucosal and bacterial cells from the nasal epithelium. This inflammatory response caused 
by the immune system does seem to influence the microbiota, possibly by forming an 
environment inhospitable to the maintenance of a healthy nasal microbiome. Pathogens 
of the Mycoplasma genus are considered to be “ideal parasites” in that the damage to the 
host is associated with immune defenses and not from direct effects of the pathogens 
themselves (Razin et al. 1998). Nevertheless, immune responses to mycoplasma are 
frequently intermittent and ineffective at fully removing the pathogen, resulting in 
chronic infections (Razin et al. 1998). The decrease in richness with the presence of nasal 
discharge could cause a decrease in pathogen over the short term, but this shift in 





Tortoise upper respiratory tracts harbor thousands of bacterial types, forming 
diverse community assemblages. The presence of pathogens and disease may alter the 
natural microbiome in tortoise hosts, depending on both the pathogen and host in 
question. Importantly, clinical signs of disease, associated with inflammation and 
sloughing off of cells, could dramatically alter the upper respiratory microbiome, and 
long-term effects of microbial shifts is yet unknown. The tortoise upper respiratory 
microbiome is diverse and likely important for normal host physiology; the role of 
tortoise interactions, wet and dry seasons, and ontogenetic changes in the maintenance 
and stability of the microbiome is yet to be addressed.  
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TABLE 1. Sites sampled representing four North American Gopherus tortoise species, 
with sample size, average (± s.d.) number of sequences per sample, number of samples 
with Mycoplasma agassizii and M. testudineum (adjusted sample size for missing data), 
number of individuals with nasal mucus at the time of sampling, and number of samples 
with Pasteurella testudinis (Chelonobacter). 
	 n	 Sequences	 M.	ag.	 M.	test.	 Mucus	 P.	test.	
G.	agassizii	 	 	 	 	 	 	
			Eldorado	 11	 2168	±	1970	 10	 7	 0	 4	






















G.	morafkai	 	 	 	 	 	 	
			Cave	Buttes	 7	 2993	±	2533	 3	 3	 0	 2	
			Silverbell	 11	 2666	±	2808	 0	 0	 0	 7	
			Sugarloaf	 13	 4631	±	3558	 11	 4	 0	 11	
G.	berlandieri	 	 	 	 	 	 	
			Chaparral	WMA	 13	 3034	±	2486	 0	 4	 0	 9	
			East	Rio	Grande	 12	 2032	±	1547	 4	 4	 0	 5	
			West	Rio	Grande	 11	 1627	±	903	 1	 2	 0	 7	
G.	polyphemus	 	 	 	 	 	 	
			Perdido	 13	 4352	±	1468	 5	 0	 2	 12	
			Rayonier	 11	 3341	±	1296	 3	 3	 0	 9	












FIGURE 1. OTU richness in North American Gopherus tortoises. (a) Correlation between 
OTU richness and the number of sequences in a sample (F(1,133) = 31.57, P < 0.0001). (b) 
Boxplot of residuals of the correlation presented in (a), separated by tortoise host species. 
(c) Boxplot of residuals of OTU richness in three sampling locations of Sonoran desert 
tortoises (G. morafkai). Letters above the boxplots denote significantly different groups. 





















FIGURE 2. Proportion of bacterial taxa in rarefied samples. (a) Bacterial phyla represented 
in the four Gopherus tortoise host species. (b) Classes representing at least 5% of the 








FIGURE 3. Principal coordinates analysis of nasal bacterial communities in four North 
American Gopherus tortoise host species from unweighted Unifrac distance matrices. (a) 
Communities of 1000 sequences per sample. (b) Data excluding sequences identified as 
Chelonobacter, with data rarefied to 500 sequences per sample. Closed circles = 
Chelonobacter was present in the sample; Open boxes = Chelonobacter not detected in 
the sample. (c) Diversity of Chelonobacter populations in tortoise host species. (a-c) 
Color-coded by host species: Red = G. agassizii; Orange = G. morafkai; Green = G. 






FIGURE 4. Core microbiome, designated as OTUs present in 75% of samples per sampling 
















FIGURE 5. Effects of nasal mucus on upper respiratory bacteria in Mojave desert tortoises 
(Gopherus agassizii). (a) Boxplots of residuals of OTU richness (vs. number of 
sequences) with and without nasal discharge of mucus (F = 16.26, P = 0.0006). Boxplots 
indicate the median, interquartile range, and reasonable range of the data. (b) Principal 
coordinates analysis, with unweighted Unifrac distance matrix, in tortoises with (closed 






The research presented in this dissertation addresses a number of questions 
regarding the ecology of host-pathogen interactions, in addition to interactions with other 
members of the microbial community, in the context of tortoise upper respiratory tract 
disease. From thorough sampling of the nasal flora of individuals in four species of 
tortoises, two mycoplasmal pathogens were found in four host species, but prevalence of 
these pathogens differed among local populations. Co-infection of two mycoplasmas was 
also found across the tortoise species, but in statistically different patterns among host 
species. Furthermore, pathogens interact within the microbial community differently 
among hosts, as presence of Mycoplasma agassizii was only found to influence 
community composition in the two species of desert tortoise. Microbiome data also had 
very high diversity of Pasteurella testudinis, a third pathogen in this system. Lastly, the 
presence of clinical signs of disease was not predicted by infection or co-infection 
patterns, though mucus as a clinical sign of URTD was associated with declines in 
microbiome richness and a shift in bacterial community composition.  
The intersection of pathogens, other microbes, hosts, and their environment forms 
a complicated web of disease ecology. The results in this dissertation introduce many 
new questions yet to be addressed. Sequencing of three genetic markers of M. agassizii 
did not detect meaningful differentiation, and thus we have yet to address questions of 
co-evolution between hosts and pathogens or variation in virulence. While it is possible 
that the lack of genetic variation found here represents genomic variation present in the 




best address evolutionary and disease-related questions in this pathogen. Regarding co-
infection dynamics, we know nearly nothing about how pathogens interact with each 
other in this system, and how those interactions differ among host species. Experimental 
inoculation studies and long-term monitoring of wild individuals would answer whether 
and how the order of infection by multiple pathogen types influences manifestation of 
disease, and how those infections and co-infections perturb a healthy upper respiratory 
microbiome. In Texas tortoises, M. agassizii was only found in co-infection with M. 
testudineum, and this difference in pattern from other host species, if not a statistical 
product of small sample size, suggests additional differences in disease ecology among 
North American tortoise hosts. Importantly, research should also focus on how human 
settlements and encroachment affect pathogen transmission and disease manifestation.  
Most research in this field has focused on Mojave desert tortoises and gopher 
tortoises, largely in the context of concern due to population declines. While tortoises are 
not model species in the conventional sense, population perturbations from habitat 
degradation or decline and climate change could send these long-lived species down a 
slippery slope toward extinction.  
 
